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A B S T R A C T
Background
Cognitive impairments, particularly memory problems, are a defining feature of the early stages of Alzheimer’s disease (AD) and vascular
dementia. Cognitive training and cognitive rehabilitation are specific interventional approaches designed to address difficulties with
memory and other aspects of cognitive functioning. The present review is an update of previous versions of this review.
Objectives
The main aim of the current review was to evaluate the effectiveness and impact of cognitive training and cognitive rehabilitation for
people with mild Alzheimer’s disease or vascular dementia in relation to important cognitive and non-cognitive outcomes for the person
with dementia and the primary caregiver in the short, medium and long term.
Search methods
The CDCIG Specialized Register, ALOIS, which contains records from MEDLINE, EMBASE, CINAHL, PsycINFO, LILACS and
many other clinical trial databases and grey literature sources, was most recently searched on 2 November 2012.
Selection criteria
Randomised controlled trials (RCTs), published in English, comparing cognitive rehabilitation or cognitive training interventions with
control conditions, and reporting relevant outcomes for the person with dementia and/or the family caregiver, were considered for
inclusion.
Data collection and analysis
Eleven RCTs reporting cognitive training interventions were included in the review. A large number of measures were used in the
different studies, and meta-analysis could be conducted for 11 of the primary and secondary outcomes of interest. Several outcomes
were not measured in any of the studies. The unit of analysis in the meta-analysis was the change from baseline score. Overall estimates
of treatment effect were calculated using a fixed-effect model, and statistical heterogeneity was measured using a standard Chi2 statistic.
One RCT of cognitive rehabilitation was identified, allowing examination of effect sizes, but no meta-analysis could be conducted.
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Main results
Cognitive training was not associated with positive or negative effects in relation to any reported outcomes. The overall quality of the
trials was low to moderate. The single RCT of cognitive rehabilitation found promising results in relation to a number of participant
and caregiver outcomes, and was generally of high quality.
Authors’ conclusions
Available evidence regarding cognitive training remains limited, and the quality of the evidence needs to improve. However, there is still
no indication of any significant benefit derived from cognitive training. Trial reports indicate that some gains resulting from intervention
may not be captured adequately by available standardised outcome measures. The results of the single RCT of cognitive rehabilitation
show promise but are preliminary in nature. Further, well-designed studies of cognitive training and cognitive rehabilitation are required
to obtainmore definitive evidence. Researchers should describe and classify their interventions appropriately using available terminology.
P L A I N L A N G U A G E S U M M A R Y
Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Dementia due to Alzheimer’s and vascular disease is an enormous public health problem. Currently, an estimated 36 million people
worldwide live with dementia, and this number is expected to increase to more than 115 million by the year 2050. Effective interventions
to reduce the burden of disease are urgently needed. Cognitive training and cognitive rehabilitation are non-pharmacological methods
that aim to help people with early-stage dementia make the most of their memory and cognitive functioning despite the difficulties
they are experiencing. Cognitive training focuses on guided practice on a set of tasks that reflect particular cognitive functions, such
as memory, attention or problem-solving. Cognitive rehabilitation focuses on identifying and addressing individual needs and goals,
which may require strategies for taking in new information or compensatory methods such as using memory aids.
This review included 11 trials of cognitive training and a single trial of cognitive rehabilitation. We found no evidence for the efficacy
of cognitive training in improving cognitive functioning, mood or activities of daily living in people with mild to moderate Alzheimer’s
disease or vascular dementia; however the quality of the studies was generally not high. The single trial of cognitive rehabilitation
provided preliminary indications of the potential benefits of individual cognitive rehabilitation in improving activities of daily living
in people with mild Alzheimer’s disease. More high-quality trials of both cognitive training and cognitive rehabilitation are needed to
establish their efficacy for people with early-stage dementia.
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B A C K G R O U N D
Cognitive impairment is a defining feature of dementia caused
by neurodegenerative conditions such as Alzheimer’s disease (AD)
and cerebrovascular disease. In the milder stages of dementia, cog-
nitive impairments are often themost disabling and distressing fea-
tures for the individual and for the family. For the person with de-
mentia, memory and other cognitive difficulties can have a major
impact on self-confidence and can lead to anxiety, depression and
withdrawal from activities, which in turn can make the difficulties
seem worse. This is an example of what has been termed ’excess
disability’ (Reifler 1990). Family caregivers are also affected by the
practical impact of cognitive problems on everyday life and by the
strain and frustration that can result. Interventions designed to
assist with aspects of cognitive functioning such as memory prob-
lems are therefore important in the milder stages of dementia, as
they may allow the person greater independence and can poten-
tially minimise the risk of excess disability. The current review is
an update of previous versions of this review (Clare 2003; Clare
2008).
Description of the condition
AD and cerebrovascular disease are the most common aetiolo-
gies underlying dementia among older individuals (Alzheimer’s
Disease International 2009). Dementia due to AD is generally
characterised by an insidious onset; vascular dementia is often as-
sociated with a more rapid onset. However, both disorders have a
progressive course that eventually culminates in global cognitive
impairment and compromised functional independence. During
milder stages, clinical signs typically include forgetfulness for re-
cent events and other cognitive impairments such as word-finding
difficulties or increased confusion in navigating unfamiliar envi-
ronments. These signs often precede the formal diagnosis by sev-
eral years, but they can be difficult to distinguish from the com-
mon forgetfulness associated with normal ageing-a factor that of-
ten leads to delays in bringing the situation to medical attention.
During this pre-dementia phase, there is often no, or minimal,
impairment in the ability of the individual to carry out most ac-
tivities of daily living. With disease progression, difficulties de-
velop in most other cognitive domains, such as semantics, praxis
and executive functioning. Functional impairment also becomes
increasingly evident. In more advanced dementia, most cognitive
and functional abilities are profoundly impaired, and behavioural
changes such as apathy, depression, aggression and agitation are
frequently observed (Lyketsos 2002; Mortby 2011).
On neuropsychological examination, the earliest signs are almost
invariably related to episodic memory function, particularly in the
person with AD. Deficits in new learning and delayed recall of
information precede the diagnosis by several years (Arnaiz 2003;
Collie 2000). Studies have established that associative memory
functions, particularly the ability to form arbitrary inter-modal
and intra-modal associations, show a striking deficit very early in
AD (Fowler 2002; Lowndes & Savage 2007). Although deficits
noted on measures of episodic memory are central to vascular
dementia, people with vascular dementia display a more striking
deficit on executive and attention tasks, as well as on measures of
semantic knowledge and visuospatial function (Graham 2004)
Pathologically, AD is characterised by the build-up of extra-cel-
lular Aβ plaques and intra-cellular neurofibrillary tangles, which
spread in a predictable and well-described manner through corti-
cal and subcortical regions (Braak & Braak 2012). In the case of
both Alzheimer’s and vascular pathology, the pathological cascade
commences years or even decades before the onset of obvious clin-
ical symptoms, at which stage individuals are increasingly brought
to clinical attention.
Description of the intervention
Cognition-focused interventions as a group fall under the broader
umbrella of non-pharmacological interventions. Cognition-fo-
cused interventions can be broadly defined as interventions that
directly or indirectly target cognitive functioning as opposed to
interventions that focus primarily on behavioural (e.g. wander-
ing), emotional (e.g. anxiety) or physical (e.g. sedentary lifestyle)
function. Several types of cognition-based interventions have been
described. The potential benefits of non-specific stimulation of
cognitive functioning for people with dementia have long been
recognised. These interventions typically involve engaging the per-
son with dementia in a range of general activities and discussions,
are commonly conducted in groups and are aimed at general en-
hancement of cognitive and social functioning. A separate recent
Cochrane Review, which focuses on interventions that fall under
this category (collectively termed ’cognitive stimulation’), has con-
cluded that general cognitive stimulation and reality orientation
approaches consistently produce improvements in general cogni-
tion and, in some cases, in self-reported quality of life and wellbe-
ing, primarily for people with mild to moderate dementia (Woods
2012).
Progress in understanding the operation of memory and related
cognitive functions and of the mechanisms underpinning learn-
ing has facilitated the development of more specific approaches
designed to help maintain or enhance cognitive functioning and
wellbeing for people with AD or vascular dementia most com-
monly those in the milder stages. These more recent approaches
to cognition-based interventions are most commonly classified as
either cognitive training (or ’retraining’ or ’remediation’ or ‘brain
training’) or cognitive rehabilitation. These terms have been and
continue to be applied somewhat interchangeably in the literature
(e.g. Fernandez-Prado 2012; Giordano 2010); therefore in pre-
vious versions of this review (Clare 2003; Clare 2008), we have
offered the following broad definitions and descriptions with the
aim of clarifying the nature of these two related but distinct forms
of intervention.
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Cognitive training
Cognitive training typically involves guided practice on a set of
standardised tasks designed to reflect particular cognitive func-
tions such as memory, attention or problem-solving. Tasks may
be presented in paper-and-pencil (Davis 2001; de Vreese 1998;
Quayhagen 1995; Quayhagen 2000) or computerised (Heiss
1993;Hofmann 1996) form, ormay involve analogues of activities
of daily living (Farina 2002; Zanetti 1994; Zanetti 1997; Zanetti
2001; Loewenstein 2004; Neely 2009). Tailoring of task diffi-
culty based on individual performance level and adaptive train-
ing (i.e. adjustment of task difficulty in response to changes in
performance level) are becoming more available through comput-
erised packages (e.g. Peretz 2011). One assumption underlying
cognitive training is that practice has the potential to improve
or at least maintain functioning in the given domain. An addi-
tional assumption is that any effects of practice will generalise be-
yond the immediate training context. Although this last assump-
tion has not often been supported by the evidence (Owen 2010;
Papp 2009), some have argued that failure to produce transfer-
able benefits is related in part to problems with task design (Jaeggi
2010). Some authors have recently broadened the definition of
cognitive training to include strategy training, which involves in-
struction in and practice of strategies designed to minimise cog-
nitive impairment while enhancing performance (e.g. method of
loci, visual imagery) and cognitive exercise (Gates 2011). Cog-
nitive training may be offered through individual (Davis 2001;
de Vreese 1998; Koltai 2001; Loewenstein 2004; Farina 2002) or
group (Cahn-Weiner 2003; Koltai 2001; Ermini Fuenfsch 1995;
Kesslak 1997; Moore 2001) sessions or may be facilitated by fam-
ily members (Quayhagen 1995; Quayhagen 2000; Neely 2009)
with therapist support. In accordance with the suggestion that
cognitive training may enhance the effects of pharmacological
therapy (Newhouse 1997), some studies have evaluated the effi-
cacy of cognitive training in combination with the use of acetyl-
cholinesterase-inhibiting (Cahn-Weiner 2003; de Vreese 1998;
Loewenstein 2004) or other (Yesavage 1981; Heiss 1993) medica-
tions. In addition, cognitive training for the person with dementia
has sometimes been included as a component of supportive inter-
ventions for caregivers (Brodaty 1989; Brodaty 1997).
Cognitive rehabilitation
Historically, rehabilitation has been viewed as a process aimed at
helping people achieve or maintain an ’optimal level of physical,
psychological and social functioning’ in the context of specific
impairments arising from illness or injury (McLellan 1991), thus
facilitating participation in preferred activities and valued social
roles (WHO 2001). More recent views of rehabilitation include a
deeper appreciation of the complex interplay between disease and
ability to function: A disability may endure even once the disease
that triggered it has been eliminated, and equally, disability can
be reduced in the face of permanent injury or even chronic dis-
ease (Institute of Medicine 2011). Cognitive rehabilitation, origi-
nally developed mainly through work with younger brain-injured
people but equally applicable to progressive conditions, refers to
the rehabilitation of people with cognitive impairments. Although
the concept continues to evolve, cognitive rehabilitation generally
refers to an individualised approach to helping people with cog-
nitive impairments, by which those affected, and their families,
work together with healthcare professionals to identify personally
relevant goals and to devise strategies for addressing these (Wilson
2002). The emphasis is not on enhancing performance on cog-
nitive tasks as such, but rather on improving functioning in the
everyday context. Cognitive rehabilitation interventions aim to
tackle directly those difficulties considered most relevant by the
person with dementia and by his or her family members or sup-
porters and to target everyday situations in the real-life context.
Cognitive rehabilitation approaches tend to be implemented in
real-world settings because there is no implicit assumption that
changes instituted in one setting would necessarily generalise to
another. Goals for intervention are selected collaboratively, and
interventions are usually provided on an individual basis.
Both cognitive training and cognitive rehabilitation might be ac-
companied by (1) psychoeducational activities aimed at facilitat-
ing an understanding of cognitive strengths and difficulties, and
(2) supportive discussion related to individual emotional reactions
or other needs; where appropriate, links may be made to other
possible sources of support. Table 1 summarizes the main differ-
ences between the attributes of cognitive training and cognitive
rehabilitation.
Table 1. Selected differences between cognitive training and cognitive rehabilitation
Cognitive training Cognitive rehabilitation
Target Impairment Participation restriction
Context Structured tasks and environments Real-world setting
Focus of intervention Isolated cognitive abilities and processes Groups of cognitive abilities and processes
required to perform everyday tasks
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(Continued)
Format Individualised or group Individualised
Proposed mechanism of action Mainly restorative; sometimes combined
with psychoeducation and strategy training
A combination of restorative and compen-
satory approaches combined with psychoe-
ducation and strategy training
Goals Improved or maintained ability in specific
cognitive domains
Performance and functioning in relation to
collaboratively set goals
How the intervention might work
Cognition-based interventions for personswith acquired disorders
of the central nervous system (including traumatic brain injury,
stroke and neurodegenerative conditions) are driven by knowledge
of brain-behaviour relationships and mechanisms of injury, dis-
ease and recovery. Historically, such interventions have reflected
two broad conceptual frameworks for the recovery of function
after brain illness or injury: a traditional or restorative approach,
and a contextualised or compensatory approach (Ylvisaker 2002).
Techniques usually associated with cognitive training such as the
repeated exercise of standardised cognitive tests of increasing diffi-
culty, targeting specific cognitive domains, tend to reflect restora-
tive principles and “thrive on the lure of neuroplasticity” (Rabipour
& Raz 2012, p. 2). Evidence in support of this comes from a re-
cent functional magnetic resonance imaging (fMRI) study that re-
ported increased memory-related brain activation following cog-
nitive training in several brain regions of individuals at high risk
of dementia due to mild cognitive impairment (Belleville 2011).
Such increased brain activation may be the result of processes of
synaptic growth and repair triggered by repeated practice on stan-
dardised tests. Techniques usually associated with cognitive reha-
bilitation, on the other hand, such as optimising residual cogni-
tive abilities in impaired domains and making the most of unim-
paired cognitive abilities, lend themselves more to compensatory
approaches. For example, in relation to memory and learning, it
is well established that the processes of memory encoding and
consolidation, as well as the sub-system of declarative memory,
tend to be profoundly impaired even in the milder stages of AD
(Christensen 1998). Nevertheless, research has shown that given
appropriate conditions and support, and sufficient time, peo-
ple with dementia can retain the ability to learn and can hold
onto some information and skills despite their memory difficulties
(Bäckman 1992; Bäckman 1996; Kopelman 1985; Little 1986).
A cognitive rehabilitation approach may focus on helping peo-
ple with dementia and their families make the most of resid-
ual memory ability, for example, by identifying the best ways of
taking in important information (Bäckman 1991; Camp 1989;
Camp 2000; Clare 1999; Clare 2000; Clare 2001;Hill 1987; Clare
2002; Anderson 2001) or by carrying out important real-life prac-
tical skills (Josephsson 1993). Indeed, several learning principles
and techniques (e.g. errorless learning, spaced retrieval) have been
found to lead to improved rates of learning and memory among
patients with mild dementia (Boudreaux 2011 Clare, Wilson et al
2000; Dunn 2007). It is well documented that despite the sever-
ity of memory difficulties, certain memory systems and processes
such as implicit memory (e.g. priming, procedural memory) are
relatively preserved in the milder stages of AD and vascular de-
mentia (Brandt 1995; Morris 1996). This profile suggests that
interventions may aim to build on areas of relative strength re-
flected in preserved aspects of memory by helping patients develop
strategies for learning information via less impaired components of
the memory system. Finally, cognitive rehabilitation interventions
also attempt to assist patients in developing ways to compensate
for impairments in those aspects of memory that are significantly
affected (e.g. using external memory aids, making environmental
changes), so as tominimise the cognitive demands of various activ-
ities (Bird 2001; Bourgeois 1990; Clare 2000; Kurlychek 1983).
Cognitive rehabilitation interventions use these and other tech-
niques to enhance or maintain everyday functioning and wellbe-
ing and to reduce excess disability for the person with dementia,
while reducing strain for family caregivers.
Why it is important to do this review
Both pharmacological treatments with cholinesterase inhibitors
and cognition-based interventions can be defined as symptomatic
treatments in that they do not target hypothesised disease mecha-
nisms. Extensive efforts to develop disease-modifying treatments
continue; however, consistently disappointing results from drug
trials of various agents have resulted in considerable doubt that
disease-modifying treatments can show a positive effect by the
time dementia is fully developed (Salomone 2012), and efforts in
this direction are increasingly being shifted to the pre-dementia
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or even the pre-symptomatic stage. In contrast, non-pharmaco-
logical interventions, particularly cognition-based interventions,
are increasingly recognised as an important adjunct and in some
cases as an alternative to pharmacological treatments for individ-
uals with dementia and those at risk of dementia. Nevertheless,
earlier studies suggested that cognition-based interventions are not
appropriate, as they are ineffective and result in frustration and
depression among participants and caregivers (Small 1997). With
growing emphasis on early detection and intervention in demen-
tia care, the need for a clear evidence base for cognition-focused
interventions is becoming apparent (Woods & Clare 2006). As
was already mentioned, a recent systematic review concluded that
general cognitive stimulation and reality orientation provide ben-
efit in terms of the overall cognitive status of patients and aspects
of their wellbeing (Woods 2012). Whether or not more targeted
approaches such as cognitive training and cognitive rehabilitation
can produce similarly encouraging outcomes has not yet been de-
termined.
The present review is an update of the original review and up-
dated versions of this review (Clare 2003; Clare 2008). The lat-
est update of this review included 9 randomised controlled trials
(RCTs) of cognitive training and found no evidence for efficacy of
cognitive training in relation to cognitive outcomes for the person
with dementia. No RCTs of cognitive rehabilitation were found
in searches for previous versions of this review; therefore no con-
clusions could be drawn regarding the efficacy of this type of in-
tervention.
In selecting studies for this review, we have classified interventions
on the basis of the ways in which they are described in relation to
the definitions previously provided. In some cases, this led to clas-
sification of an intervention as ‘cognitive training’ even when the
term ‘cognitive rehabilitation’ was used by the study authors. In
other cases, an intervention described as ‘cognitive training’ might
be deemed to fit more closely with the principles of ‘cognitive
stimulation’, thus leading to exclusion from the current review.We
acknowledge that the identified categories represent broad defi-
nitions and that some cases may reflect an overlap between tech-
niques found in cognitive ’training’ and those classified as cog-
nitive ’rehabilitation’, which in turn may have some commonali-
ties with cognitive ’stimulation’. Therefore, although the current
classification of cognition-based interventions is gradually gaining
some consensus among researchers, this classification should re-
main open to additional refinement in the future.
O B J E C T I V E S
• To evaluate the effects of cognitive training and cognitive
rehabilitation for people with mild AD or vascular dementia in
relation to cognitive and non-cognitive outcomes for individuals
affected and for their caregivers.
• To update previous versions of this review (Clare 2003;
Clare 2008).
• To consider the nature and quality of available evidence on
this topic as derived from RCTs.
• To assist in establishing the appropriateness of cognitive
training and cognitive rehabilitation interventions offered to
people with early-stage dementia and, where relevant, to identify
the factors associated with efficacy.
M E T H O D S
Criteria for considering studies for this review
Types of studies
• Randomised controlled trials for which adequate
information was provided or could be obtained from the
researchers were considered for inclusion. For consistency with
previous versions of the review, we decided to include only
studies that were published in the English language. Although in
some cases this may lead to an increased language bias, evidence
suggests that the effects of language bias have diminished as a
result of the continuous shift towards publishing of trial results
in English (Sterne 2011). No study was excluded solely on the
basis of language other than English, as whole non-English
studies that were screened beyond the title (n = 3) were found to
fail other inclusion criteria (non-randomised trials or trials of
cognitive stimulation).
Types of participants
• Participants with a medical diagnosis of dementia, possibly
further specified as Alzheimer’s disease, vascular dementia or
mixed Alzheimer’s and vascular dementia according to the
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV),
the International Classification of Diseases, Tenth Revision (ICD-
10), criteria of the National Institute of Neurological and
Communicative Disorders
Alzheimer’s Disease and Related Disorders Association
(NINCDS-ADRDA) or research diagnostic criteria of the
National Institute of Neurological Disorders and Stroke and
Association Internationale pour la Recherché et l’Enseignement
en Neurosciences (NINDS-AIREN) (APA 1995; WHO 1992;
McKhann 1984; Roman 1993). Given common limitations of
available data regarding specific diagnoses, we decided to
consider these diagnostic categories together. We excluded data
from participants for whom dementia was known to have an
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aetiology other than AD or cerebrovascular pathology (e.g.
frontotemporal dementia, Lewy body dementia), as the format
of cognitive training and rehabilitation in other dementia types is
likely to differ substantially from that applied in AD or vascular
dementia.
• We included only studies that reported the severity of
dementia through group mean scores, ranges of scores or
individual scores on a standardized scale such as the Mini-Mental
State Examination (MMSE; Folstein 1975) or the Clinical
Dementia Rating (CDR; Hughes 1982).
• Studies targeting primarily people with minimal, mild or
moderate dementia (MMSE score > 12 or CDR score < or = 2),
although studies with a small proportion of participants in the
more severe ranges (< 20%) were considered acceptable.
• Qualifying participants were expected in the main to be
residing at home, but interventions might be offered in a range
of settings, and data from home, outpatient, day-care and
residential settings were considered acceptable for inclusion.
However, it was considered appropriate to exclude data from
long-term residents of psychiatric hospitals, where pre-existing
psychiatric conditions were likely to occur.
• No specific restrictions were set regarding age. Although it
was previously planned to examine the potential moderation of
age on observed outcomes, given the limited data available, it
was decided not to examine the role of age at this point.
• No restrictions were placed on current pharmacological
treatment. Where available, we noted information about
participants’ use of cholinesterase inhibitors.
• It was decided that data from family caregivers would be
included where available, and where the relationship between the
caregiver and the person with dementia was specified, including
whether the two were co-residents.
• In previous versions, it was proposed that information
regarding the use of coping strategies used by participants or
caregivers to maintain or enhance cognitive function would be
noted. However, no study provided this information.
Types of interventions
Experimental interventions
• Interventions meeting our definition of cognitive training
or cognitive rehabilitation were acceptable for inclusion. These
might also be described as memory ’therapy’, ’groups’,
’retraining’, ’support’ or ’stimulation’, or as cognitive ’training’,
’retraining’, ’remediation’, ’support’ or ’stimulation’.
• Interventions were required to specifically address one or
more target areas relevant to cognitive functioning, either singly
or in combination with interventions directed at other targets
(e.g. relieving anxiety or depression) or other cognitive functions
(e.g. attention or problem-solving).
• When more than one experimental group was included in
the study, the group that provided the treatment most similar to
that described in other included studies was selected for analysis
(e.g. individual interventions were selected over interventions
delivered to dyads, and stand-alone cognitive training or
rehabilitation interventions were selected over interventions that
combined pharmacological and non-pharmacological
components).
Comparator interventions
• No treatment/standard treatment. Unless otherwise
specified, whenever groups were described as ’no treatment’ in
individual studies, it was assumed that this referred to the usual/
standard treatment, and not to withholding of treatment. ’Usual
or standard treatment’ refers to what would normally be provided
in the study locality to participants with early-stage Alzheimer’s
or vascular dementia, and might include provision of medication,
clinic consultations, contact with a community mental health
team, day care or support from voluntary organisations, but not
cognitive training or rehabilitation interventions.
• Wait-list control. In studies of this kind, the experimental
intervention was offered to the control group after the study had
ended.
• Active control condition. For example, active control
conditions consisted of an equivalent number of sessions or visits
in which general social support was provided, but during which
no structured cognitive training or rehabilitation intervention
was offered.
• When more than one comparator intervention was
included in the study, the group that was most similar to that
included in other studies was selected for analyses. This was
usually a ’no treatment’ group.
All interventions
• Interventions conducted in individual or group modalities,
with or without involvement of family caregivers, were
acceptable for inclusion.
• Interventions included at least a baseline assessment and an
immediate post-intervention assessment, with or without follow-
up assessment.
• No restrictions were imposed regarding duration of
intervention or number of treatment sessions. It was decided to
consider differences in these parameters when making
comparisons between studies.
Types of outcome measures
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Primary and secondary outcomes were examined in three cate-
gories:
• Cognitive and non-cognitive outcomes of the intervention
for the person with dementia
• Outcomes for the primary caregiver
• The impact of the intervention on the course of the disorder
Outcomes for the person with dementia and for the primary care-
giver were considered for inclusion in the meta-analysis when they
were assessed using scores on at least one standardised test or ques-
tionnaire measure. When more than one measure was used to as-
sess a particular outcome (e.g. immediatememory), we included in
the comparison the measure on which group differences were ob-
served at post-intervention or follow-up assessments (if relevant),
or the measure that ,most resembled the measures contributed by
other studies. Behavioural observations and ad hoc measures were
considered as additional information.
Rates of attrition and reasons for attrition were noted where avail-
able. Drop-out rates in the context of progressive conditions may
in part reflect changes in the needs of the individual that prompted
a needed change in therapeutic approach. With a progressive con-
dition, individual needs may change during the course of an in-
tervention and follow-up period, requiring implementation of a
different approach, but this should not be interpreted as evidence
that the approach itself is ineffective.
Outcome measures for the person with dementia seek to identify
whether changes are observed after the intervention, and to de-
termine the extent to which these can be attributed to the inter-
vention itself. Given the progressive nature of dementia, improved
performance may not necessarily be a goal. Instead, preserved per-
formance on a trained task in the context of a decline in untrained
tasks could be interpreted as evidence of efficacy. Differences in
the trajectory of change between scores on intervention targets
and standardised measures are as important as the overall level of
change; for example, maintenance of functioning on a target task
in the context of a decline in scores on standardised assessments
might indicate that the intervention was effective in relation to
the targeted area of functioning.
Primary outcomes
For each of the outcomes described previously, we intended to con-
duct separate comparisons for those measured short term (imme-
diately post-intervention), medium term (3 to 12 months post-in-
tervention) and long term (> 12months post-intervention). How-
ever, no study reported relevant outcomes beyond the medium
term.
(A) Cognitive outcomes for the person with dementia
• (A1) Change in scores on global cognitive screening
measures (e.g. MMSE) and in orientation and self-reported and
caregiver-reported cognitive abilities in the short term (i.e.
immediately post-intervention
A1.1), in the medium term (i.e. 3 months up to one year
A1.2) and in the long term (i.e. longer than a year
A1.3).
• (A2) Change in performance on neuropsychological
measures (immediate and delayed memory, working memory
and attention, language, executive function) in the short term
(i.e. immediately post-intervention
A2.1), in the medium term (i.e. 3 months up to one year
A2.2) and in the long-term (i.e. longer than a year
A2.3).
(B) Non-cognitive outcomes for the person with dementia
• Self-reported or caregiver-reported changes in mood,
capacity for activities of daily living, behaviour, adjustment to
disability, general health and quality of life in the short term
(B1), in the medium term (B2) and in the long-term (B3).
Secondary outcomes
(C) Outcomes regarding the course of dementia
• Change in scores on measures of dementia severity (e.g.
CDR) or rates of admission to residential care in the short term
(C1), in the medium term (C2) and in the long term (C3).
(D) Outcomes for the family caregiver
• Self-reported changes in mood, wellbeing, burden of care
and quality of life in the short term (D1), in the medium term
(D2) and in the long term (D3).
(E) Outcomes for disease biomarkers of the person with
dementia
• (E1) Changes in in vivo measures of neuropathology (e.g.
amyloid or tau pathology, brain atrophy) in the short term
(E1.1), in the medium term (E1.2) and in the long term (E1.3).
• (E2) Changes in measures of brain function (e.g.
fluorodeoxyglucose positron emission tomography (FDG PET),
fMRI) in the short term (E2.1), in the medium term (E2.2) and
in the long term (E2.3).
Search methods for identification of studies
Electronic searches
We searched ALOIS (www.medicine.ox.ac.uk/alois)
the Cochrane Dementia and Cognitive Improvement Group’s
Specialized Register on 2 November 2012.
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ALOIS is maintained by the Trials Search Co-ordinator of the
CochraneDementia and Cognitive ImprovementGroup and con-
tains studies in the areas of dementia prevention, dementia treat-
ment and cognitive enhancement in healthy individuals. Studies
are identified from the following:
• Monthly searches of a number of major healthcare
databases: MEDLINE, EMBASE, CINAHL, PsycINFO and
LILACS.
• Monthly searches of a number of trial registers, including
ISRCTN; UMIN (Japan’s Trial Register); the WHO portal
(which covers ClinicalTrials.gov; ISRCTN; the Chinese Clinical
Trials Register; the German Clinical Trials Register; the Iranian
Registry of Clinical Trials and the Netherlands National Trials
Register, plus others).
• Quarterly search of The Cochrane Central Register of
Controlled Trials (CENTRAL).
• Six-monthly searches of a number of grey literature sources,
including ISI Web of Knowledge Conference Proceedings; Index
to Theses; Australasian Digital Theses.
To view a list of all sources searched for ALOIS, see About ALOIS
on the ALOIS Website.
Details of the search strategies used for retrieval of reports of tri-
als from healthcare databases, CENTRAL and conference pro-
ceedings can be viewed in the ‘Methods used in reviews’ sec-
tion within the editorial information about the Dementia and
Cognitive Improvement Group.
Additional searches were performed using many of the sources
previously listed to cover the time frame from the last searches
performed for ALOIS, to ensure that the search for the review
was as up-to-date and as comprehensive as possible. The search
strategies used can be seen in Appendix 1.
Searches carried out in previous versions of the review can be
viewed in Appendix 2 and Appendix 3.
Data collection and analysis
Selection of studies
The search results (covering the period April 2006 November
2012) were reviewed by one review author (AB-F), who identi-
fied all relevant RCTs of cognition-based interventions in mild
AD or vascular dementia and retrieved the full texts. Two review
authors (AB-F and LC) then independently reviewed each article
to determine whether inclusion criteria were met. There were no
disagreements regarding the inclusion of studies.
Data extraction and management
All relevant data were extracted from the studies selected for inclu-
sion, recorded on a data entry form and entered into ReviewMan-
ager (RevMan). Additional information was sought from study
authors as appropriate. Data extracted from each trial included
characteristics of the experimental and control groups used in each
study, as well as characteristics of the interventions provided.Mean
scores and standard deviations from baseline, post-intervention
and, where available, follow-up assessments on all relevant out-
come measures for treatment and comparison groups were also
extracted. Two studies (Koltai 2001; Beck 1988) directly reported
the data in terms of change from baseline. In the remaining stud-
ies, changes from baseline statistics were calculated from group
means and standard deviations at baseline, post-intervention and
follow-up. Baseline was defined as the latest assessment available
before randomisation, but no more than two months before.
Assessment of risk of bias in included studies
Assessment of risk of bias was conducted by AB-F using The
Cochrane Collaboration’s Risk of Bias tool (Higgins 2011) and
was subsequently reviewed by LC. Consistent with the risk of bias
tool, study quality was assessed in the following domains: sequence
generation, allocation concealment, blinding of participants and
investigators, incomplete outcome data and selective reporting of
outcomes. Studies were rated as ’low risk’, ’high risk’ or ’unclear
risk’ in each of these domains. There were no disagreements be-
tween review authors in ratings of risk of bias.
Measures of treatment effect
Themeta-analysis was conducted on change-from-baseline scores.
A zero correlation between measurements at baseline and those at
subsequent time points was assumed. This method overestimates
the standard deviation of the change from baseline but provides
a conservative approach considered to be preferable in a meta-
analysis. Outcome measures were treated as continuous measures.
In some cases, outcomes were derived from ordinal rating scales;
provided these contained a reasonably large number of categories
(> 10), the data were treated as continuous variables arising from
a normal distribution. There were no examples of binary outcome
measures, which would have required an odds ratio calculation.
The mean difference (MD) with 95% confidence interval (CI)
was used whenever studies used the same outcome measure, and
the standardised mean difference (SMD), which is the absolute
mean difference divided by the pooled standard deviation, was
used when the same outcome was assessed with the use of different
measures.
Unit of analysis issues
Three types of unit of analysis issues were encountered: cross-over
trial designs, multiple treatment groups and repeated assessments.
For cross-over trials, only data from the first treatment period were
used. In the case of studies that comparedmore than two treatment
groups, the analysis focused on the two groups providing the most
pertinent data that most resembled conditions included in other
12Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
studies. Wherever possible, a condition in which individual cog-
nitive training or rehabilitation was delivered was compared with
a condition that included no cognitive intervention. To address
the issue of repeated assessments (more than one post-intervention
assessment), we intended to conduct separate comparisons to as-
sess outcomes immediately post-intervention (the first post-inter-
vention assessment), short-term outcomes (up to 12 months post-
intervention) and longer-term outcomes (more than 12 months
post intervention).
Dealing with missing data
Numbers of participants who commenced andwho completed the
intervention in each group were noted where available, and these
numbers contributed to the assessment of risk due to incomplete
outcomes data. Studies generally provided minimal detail on the
causes and impact of missing data. In general, it was assumed that
data were missing at random, and analyses in individual studies
were generally performed per protocol rather than on an intention-
to-treat basis.
Assessment of heterogeneity
Statistical heterogeneitywas assessed using a standardChi2 statistic
and an associated l2 statistic. Consistent with recommendations,
heterogeneity was deemed to be present when the Chi2 statistic
was significant at the P = 0.1 level, or when the l2 suggested that
more than 40% of the variability in effect estimate was due to
heterogeneity (Higgins 2011).
Data synthesis
As no evidence of statistical heterogeneity was found, all analyses
were conducted using a fixed-effect model and the inverse variance
method.
Subgroup analysis and investigation of heterogeneity
As no heterogeneity was detected, no subgroup analyses were con-
ducted.
Sensitivity analysis
Inflated estimates of the standard deviation of change scores, asso-
ciated with the assumption of zero correlation between pre-inter-
vention and post-intervention scores on outcome measures, can
potentially obscure real effects of the interventions. To address this
possibility, we re-ran the meta-analysis for some of the central out-
come measures using post-intervention scores only, thus avoiding
the need to estimate the standard deviation of change scores. This
sensitivity analysis did not lead to a change in any of the results
reported here.
R E S U L T S
Description of studies
Results of the search
Electronic searches conducted in November 2012, December
2011 and September 2009 retrieved a combined total of 1339
results. Following preliminary screening and removal of dupli-
cate studies by Anna Noel-Storr, Trial Search Co-ordinator of
the Cochrane Dementia and Cognitive Improvement Group, 495
records were forwarded to the review authors for further evalua-
tion. After title and abstract review by one review author (AB-F),
49 records were selected for closer assessment, and full records were
retrieved and reviewed independently by two review authors (AB-
F, LC). Upon review and discussion, three trials were identified
that met the inclusion criteria two trials describing a cognitive
training intervention (Galante 2007; Neely 2009) and one trial
describing a cognitive rehabilitation intervention (Clare 2010).
The two cognitive training studies were added to the nine studies
that were included in the previousmeta-analysis, bringing the total
number of studies in the meta-analysis to 11. Because no previous
trials on individualised cognitive rehabilitation had been under-
taken, no meta-analysis of cognitive rehabilitation could be per-
formed. The flow of studies through the review process is shown
in Figure 1.
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Figure 1. Study flow diagram.RCT = randomised controlled trial.CT = cognitive training.CR = cognitive
rehabilitation.
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Additional information
Additional information was sought from study authors where nec-
essary. With regard to de Vreese 1998, another abstract was pub-
lished in 1999 (see under de Vreese 1998), additional data were
reported in a later review article (see under de Vreese 1998) and
further information including mean scores was kindly supplied
by the author. Additional data related to Loewenstein 2004 were
also kindly supplied by the author. Queries related to Koltai 2001,
Beck 1988, Quayhagen 1995, Quayhagen 2000, Galante 2007
and Heiss 1993 were answered by the investigators. No responses
were received to queries related to the studies by Davis 2001,
Cahn-Weiner 2003 and Neely 2009.
Included studies reported that a total of 117 measures (100 mea-
suring patient outcomes, 17 measuring caregiver outcomes) were
used to examine the 22 primary and secondary outcomes selected
for examination in this review. For cognitive training interven-
tions, data for meta-analysis were available for 8 of the 14 primary
outcomes and for 6 of the 8 secondary outcomes over the short
term. Meta-analysis could be performed on 2 of 14 primary out-
come measures and on 2 of 8 secondary outcome measures over
the medium term. No cognitive training studies reported an out-
come measure over the long term. As only one study of cognitive
rehabilitation met inclusion criteria for this review, no meta-anal-
ysis of cognitive rehabilitation could be conducted.
Included studies
Significant diversity was noted among the 12 studies on a range
of parameters. Seven studies included only participants diagnosed
with AD, but the other four included participants diagnosed
with AD, vascular dementia or mixed dementia. In one study
(Quayhagen 2000), participants were included if they were diag-
nosed with dementia due to Parkinson’s disease (PD) in addition
to AD and vascular and mixed dementia, but it was not possible to
ascertain how many of the included participants had PD, because
data for all aetiologies were reported together. Severity of dementia
varied in the included studies from verymild tomoderate; this was
generally determined on the basis of scores on ameasure of demen-
tia severity or global cognition (e.g. Clinical Dementia Rating,
MMSE). Although not stated explicitly in most studies, it appears
that in most cases, patients were recruited from the community;
in a small number of studies, patients who resided in residential
care homes were also included. The duration of interventions pro-
vided in the included studies varied considerably, ranging from 4
to 24 weeks. Four studies reported follow-up assessments over the
medium term; these occurred at 8 weeks, as well as at 3, 6 and
9 months, after the end of treatment. The content of the inter-
ventions also varied considerably, ranging from training in the use
of compensatory strategies to practice on computerised tasks to
working toward achieving collaboratively derived goals. Selected
features of the included studies are further described here and are
summarised in the Characteristics of included studies table.
Objectives of the studies
Beck 1988: Compared ’cognitive skills remediation training’, de-
livered on a one-to-one basis, with a usual-treatment control con-
dition.
Heiss 1993:Compared computerised cognitive training alonewith
two conditions inwhich computerised cognitive trainingwas com-
bined with drug treatment (cognitive training plus pyritinol and
cognitive training plus phosphatidylserine) and an active control
condition (social support). The relevant comparison for this re-
view is that between cognitive training alone and social support.
Quayhagen 1995: Compared cognitive training with active and
wait-list control conditions. The relevant comparison for this re-
view is that between cognitive training and the wait-list control
condition.
de Vreese 1998: The study initially set out to compare cog-
nitive training alone, acetylcholinesterase-inhibiting medication
(AChEI) alone, cognitive training plus AChEI and placebo. Raw
data for the group receiving cognitive training alone were not re-
ported in the 1998 paper and are no longer available. The design
was subsequently amended as caregivers were dissatisfied with the
possibility of receiving cognitive training alone, so the comparisons
reported in 2001 and augmented with further information from
the author involve three groups: AChEI alone, cognitive training
plus AChEI and active control. For the purposes of this review,
the comparison of interest lies in the difference between AChEI
alone and cognitive training plus AChEI.
Quayhagen 2000: Compared four intervention approaches
cognitive training, dyadic counselling, dual supportive seminar
groups and early-stage day care with caregiver support with a
wait-list control condition. For the purposes of this review, the
comparison of interest is that between cognitive training and the
wait-list control condition.
Davis 2001: Compared cognitive training with a ’mock’ (active
control) intervention in a cross-over design. The comparison of
interest is that between training and active control groups follow-
ing the initial intervention stage; cross-over data are not consid-
ered here.
Koltai 2001: Compared a memory and coping programme, deliv-
ered in individual or group session format, with a wait-list control
condition. The results for individual and group training were anal-
ysed together in the trial report as no differences were observed
between them.
Cahn-Weiner 2003: Compared a memory training programme
delivered in small-group format with a control condition involving
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didactic presentation.
Loewenstein 2004: Compared ’cognitive rehabilitation training’
with ’mental stimulation’, delivered in one-to-one sessions.
Galante 2007:Compared individual computerised cognitive train-
ing with an active control condition.
Neely 2009: Compared collaborative cognitive training (dyadic),
individual cognitive training and ano treatment control condition.
The relevant comparison for this review is that between individual
cognitive training and no treatment groups.
Clare 2010: Compared individual, goal-oriented cognitive reha-
bilitation with relaxation therapy, and with a no treatment control
condition. The relevant comparison for this review is that between
the cognitive rehabilitation and no treatment groups.
Participant numbers and characteristics in the overall
samples
Beck 1988: Participants included 20 individuals over 55 years
of age with moderately impaired cognitive functioning (MMSE
score of 15 to 20) and findings compatible with a diagnosis of
Alzheimer’s disease or mixed dementia, living in one of four nurs-
ing homes or in the geriatric unit of a Veterans Administration
hospital.
Heiss 1993: Of 80 people who entered the study, data were
available for 70. Included in this group were 37 men and 33
women with a diagnosis of possible or probable AD according
to NINCDS-ADRDA criteria and a modified Hachinski score of
3 or less, ranging in age from 48 to 79 years (average age 66.63
years), and withMMSE scores ranging from 13 to 26. On entry to
the study, none were taking any medications known to affect the
central nervous system. This study was carried out in Germany.
Quayhagen 1995: Of 135 care recipient/caregiver dyads initially
assessed, 95were eligible for inclusion, 79 completed the study and
data were available for 78. These were families in which one person
had a diagnosis of possible/probable AD and was in the mild or
moderate stage with a Mattis Dementia Rating Scale (DRS) score
of 90 or above. People with dementia included 51 men and 27
women, with an average age of 73.6 years (standard deviation
(SD) 8.0) and an average education level of 12.6 years (SD 4.1).
They were not participating in any clinical trials of anti-dementia
medication. Caregivers consisted of 18 men and 60 women, with
an average age of 66.7 years (SD 10.8) and an average education
level of 14.1 years (SD 2.7). Twenty-nine percent of caregivers
attended support groups periodically, and 14% had previously
sought psychological help. This studywas conducted inCalifornia,
USA, and ethnicity within the whole sample was described as 85%
white, 3% African American and 11% Hispanic.
de Vreese 1998: The 1998 paper reports the inclusion of 24 par-
ticipants with a diagnosis of AD according to NINCDS-ADRDA
orDSM-IV criteria and a CDR rating of 1 to 2. Average age was
72.6 years (range 61 to 83 years). The 2001 review paper reports
the inclusion of 27 participants with early-stage AD and MMSE
scores ranging from 20 to 26, representing the removal of the 6
people in the original cognitive training alone condition and the
addition of 3 more participants to each of the other groups. Par-
ticipants were taking no concurrent medication known to affect
the central nervous system. This study was undertaken in Italy.
Quayhagen 2000: Participants included 103 dyads consisting of
a person with dementia and a caregiving spouse. The people with
dementia had a diagnosis of possible or probable AD (more than
70% were in this category), vascular dementia or Parkinson’s de-
mentia, and were in the mild or moderate stages, scoring above
100 on the DRS. They included 65 men and 38 women, with an
average age of 74.51 years (SD 7.11) and an average education
level of 14.57 years (SD 3.05). The caregivers were 38 men and
65 women, with an average age of 71.83 years (SD 8.12) and an
average education level of 14.42 years (SD 3.05). The study took
place in California, USA, and the ethnic mix within the whole
sample was described as 93% white, 2% African American, 1%
Asian and 4% Hispanic.
Davis 2001: The participants were 37 individuals (16 men and 21
women) with a diagnosis of probable AD according to NINCDS-
ADRDA criteria. MMSE score range was 15 to 29 (average score
22.31). Average age in the sample was 70.62 years, and average
level of education was 14.02 years. Mean score on the 30-item
Geriatric Depression Scale (5.02) was within the normal range.
This study was carried out in Texas, USA.
Koltai 2001: The participants were 24 older people aged 60 to
84 with a diagnosis of AD and a CDR score of 0.5 or 1.0. Of
the 25 people initially identified as eligible, one found the group
treatment modality unacceptable and declined to take part. The
study was carried out in North Carolina, USA.
Cahn-Weiner 2003: The participants were 34 individuals (20
women and 14men) with a diagnosis of probable AD according to
NINCDS-ADRDA criteria. The study was conducted in Rhode
Island, USA.
Loewenstein 2004: The participants were 44 individuals (26 men
and 18 women) with a diagnosis of probable or possible AD ac-
cording to NINCDS-ADRDA criteria. The authors note that
those with a diagnosis of probable ADmetDSM-IV criteria for de-
mentia, and those with possible AD did not show sufficient func-
tional impairment to merit a DSM-IV diagnosis of dementia. All
participants had been on a stable dose of an acetylcholinesterase
inhibitor for 8 weeks at the start of the study; 41 of these were
taking donepezil (doses ranged from 5 to 15 mg). Approximately
two-thirds of participants were English speakers, and the remain-
ing 14 were Spanish speakers, mostly of Cuban origin, for whom
all components of the programmewere conducted in Spanish. The
study took place in Florida, USA.
Galante 2007: Participants were 12 individuals who met
NINCDS-ADRDA criteria for mild AD and scored 19 to 26 on
the MMSE or 70 to 90 on the Milan Overall Dementia Assess-
ment (MODA). All were treatedwith AChEI for at least 3months.
The mean age of the sample was 76 years (SD 6), and the mean
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educational level was 6.3 years (SD 2.2). One control participant
was excluded from analysis “due to poor compliance”. The study
was conducted in Italy.
Neely 2009: Forty-seven individuals who metDSM-IV criteria for
mild to moderate AD or vascular dementia and their spouses were
approached for the study, and 30 patients (15 males, 15 females)
consented to participate. All participants were diagnosed with de-
mentia within the 8 months immediately before the study, were
living at home with their spouses and were free from significant
psychiatric disorders. Themean age of patients was 75.4 years (SD
6.4). The study was conducted in the Stockholm area of Sweden.
Clare 2010: Participants were 69 individuals (41 women, 28 men)
with a mean age of 77.78 years (SD 6.32), and a mean education
level of 10.64 years (SD 1.67). They were diagnosed with AD (n
= 56) or mixed AD and vascular dementia (n = 13) according to
NINCDS-ADRDA criteria. ThemeanMMSE score was 23 (SD=
3.02), and all participants were on a stable dose of AChEIs. Forty-
four participants had family members involved, and in all but 4
cases, these individuals were living with the person with dementia.
The study was conducted in the North Wales area of the UK.
Characteristics of participants in the treatment and
comparison groups
Beck 1988: Characteristics of participants in the treatment and
control groups are summarised in Table 1. No significant differ-
ences were found between the two groups. Each group comprised
7 white and 3 black participants. In the treatment group 2 had
completed grade school, 6 high school and 2 college, and in the
control group, 2 had completed grade school, 7 high school and 1
college. In the treatment group 6 people resided in nursing homes
and 4 in hospital, and in the control group 9 people resided in
nursing homes and 1 in hospital.
Heiss 1993: Mean ages and gender distributions for cognitive
training and social support conditions are summarised in Table 1.
No significant differences were noted between groups.
Quayhagen 1995: Details are not reported separately for the cog-
nitive training and comparison groups, but the authors comment
that no significant differences were observed between groups.
de Vreese 1998: In the 1998 paper, groups were reportedly
matched on educational level and illness severity, although the cog-
nitive training plus AChEI group had a significantly longer dura-
tion of illness. The 2001 paper reports that groups were matched
on MMSE scores; mean MMSE scores are reported in Table 1.
Quayhagen 2000: Details are not reported separately for the cog-
nitive training and comparison groups, but the authors comment
that no significant differences were noted between groups.
Davis 2001: Characteristics of participants in each of the two
groups are summarised in Table 1. No statistically significant dif-
ferences were reported, but some trends were apparent; partici-
pants in the cognitive training group were on average younger and
better educated and were more likely to be male and to be receiv-
ing anti-depressant medication.
Koltai 2001: Characteristics of participants in training and control
groups are summarised inTable 1. Participants in the control group
had significantly higher MMSE scores at baseline (26.6 vs 22.9)
and significantly lower relative rated levels of depression on the
Geriatric Depression Scale (GDS) (8.3 vs 14.7).
Cahn-Weiner 2003: Characteristics of participants in each of the
two groups are summarised in Table 1. No statistically significant
differences were noted between the groups on these parameters.
Loewenstein 2004: Characteristics of participants in each of the
two groups are summarised in Table 1. No statistically signifi-
cant differences were noted between the groups on these parame-
ters, except that three-month follow-up was significantly later for
the cognitive training group (13.67 weeks from post-intervention,
compared with 12.79 for the mental stimulation group).
Galante 2007: The authors provided the mean age and education
level for the full sample, but no information regarding these pa-
tient characteristics was provided at the group level. In addition,
the authors report in a table themeans and SDs for the two groups
on the cognitive measures at all time points, but significance levels
are provided only for the Time × Group interaction. Therefore,
it is not possible to ascertain whether the groups were equivalent
at baseline. Visual inspection shows clear trends for group differ-
ences on a number of cognitive (e.g. prose memory), functional
(e.g. instrumental activities of daily living (IADL)) andmood (e.g.
Neuropsychiatric Inventory (NPI)) measures at baseline. Available
characteristics of participants in the training and control groups
are summarised in Table 1.
Neely 2009: Relevant characteristics of the treatment and control
groups are summarised in Table 1. The groups did not differ in
age, levels of depression, MMSE scores or subjective health, or
on any of the cognitive measures included at baseline. Data on
participants’ education level was not reported.
Clare 2010: Characterisitcs of the intervention and control groups
are summarised in Table 1. No group differences were found at
baseline in any of the demographic, cognitive or functional mea-
sures or in the presence of comorbid medical conditions.
Description of the interventions
Beck 1988: Cognitive skills remediation training included exer-
cises on attention and reading, concentration on detail and re-
membering. Exercises were graded for difficulty level, and partici-
pants were given assistance when they had problemswith the tasks.
Heiss 1993: Computerised cognitive training for one hour, twice
a week, with commercially available software designed for use in
neurological rehabilitation (produced by Rigling Reha-Service),
running on a Commodore C64 computer. Participants had to
solve memory, perceptual or motor tasks, selected according to
the profile of cognitive impairment, of varying difficulty levels.
Duration of training was 24 weeks.
Quayhagen 1995: One hour per day of active cognitive stimula-
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tion, six days per week, facilitated by the family caregiver in the
home setting, using ecologically valid exercises addressing mem-
ory, problem-solving and conversational fluency. Aworkbook pro-
vided for family caregivers contained exercises of varying difficulty
levels fromwhich they could select appropriate tasks. The exercises
were continued for 12 weeks.
de Vreese 1998: Twice-weekly, 45-minute individual sessions with
caregivers present, aimed at ’(re)training memory (in particular
autobiographical and implicit), language and executive abilities
associated with reality orientation therapy, to be repeated at home
by the caregiver’. The 2001 paper describes the sessions as 30 to
40 minutes in length and involving individually tailored memory
training exercises that provided support for encoding (use of real-
lifematerial, involvement ofmotor activity, self-generationof cues)
and for retrieval (provision of supplementary cues, use of forced-
choice recognition). The sessions were introduced after a 3-month
run-in period on the drug treatment and were continued for 12
weeks.
Quayhagen 2000: As for Quayhagen 1995, but given 5 days per
week for 8 weeks. Post-treatment assessment was carried out at 12
weeks.
Davis 2001: Weekly individual one-hour sessions at the clinic,
covering (1) spaced retrieval training for personal information (al-
though half recalled the information without training, so there
was a ceiling effect); (2) the ’peg’ task mnemonic strategy (for
those who required little or no spaced retrieval training) and (3)
face-name associationusingmnemonics.Home attention exercises
were carried out for 30 minutes per day, 6 days a week, and were
directed by the caregiver. Duration of treatment was five weeks.
Koltai 2001: The memory and coping programme was delivered
in individual or group modality. The group format consisted of
five weekly, one-hour sessions conducted in groups of four. The
individual format consisted of a mean of six individual sessions.
Caregivers joined the last 10 to 15 minutes of each session, where
available. The programme involved training andpractice in the fol-
lowing techniques: spaced retrieval, face-name recall, verbal elab-
oration, concentration/overt repetition, external memory aids and
coping strategies.
Cahn-Weiner 2003: The memory training provided was a mod-
ified version of a manualised protocol, involving practice with
memory strategies such as categorisation and visualisation and
word list learning.
Loewenstein 2004: The cognitive rehabilitation training covered
time and place orientation, face-name association learning, ob-
ject manipulation, attention and visuomotor training with a com-
puter, making change for a purchase from a $20 bill and balanc-
ing a cheque book. Participants were encouraged to use a memory
notebook and to practice what they had learned at home between
sessions.
Galante 2007: The computerised cognitive training group was
trained on a set of computerised exercises selected from a software
package covering the domains of memory, language, perception,
attention, spatial cognition and intelligence. Exercises were ad-
ministered in a fixed sequence to all participants, and most exer-
cises lasted 3 minutes.
Neely 2009: The cognitive training was conducted with the sup-
port of a research assistant. Participants were trained on a name-
face learning task and on a table-setting activity. Spaced retrieval
and the provision of letter cues were used to support training on
the face-name learning task, whereas a hierarchical cueing tech-
nique was used to support training on the table-setting activity.
Clare 2010: The focus of the intervention was addressing person-
ally meaningful goals; goals were collaboratively identified, and
individualised interventions were developed. This was supported
by the provision of practical aids and strategies, techniques for
learning new information, practice in maintaining attention and
concentration and techniques for stress management. Participants
were encouraged to work on goals and practise strategies between
intervention sessions, and caregivers were invited to participate in
the final 15 minutes of each session to assist with between-session
implementation.
Length and duration of the interventions
A summary of the duration of interventions and the timing of
assessments is shown in Table 2.
Beck 1988: The intervention was delivered in one-to-one sessions
lasting 30 to 40 minutes, held three times a week for six weeks.
Heiss 1993: Twice-weekly, one-hour individual sessions for 24
weeks.
Quayhagen 1995: One hour per day, 6 days per week, for 12
weeks, facilitated by caregiver, plus weekly session with member
of research team.
de Vreese 1998: Twice-weekly 45-minute individual sessions for
12 weeks, supplemented by home practice.
Quayhagen 2000: One hour per day, 5 days per week, for 8
weeks, facilitated by caregiver, plus modelling of the intervention
by member of the research team to assist the caregiver.
Davis 2001: Weekly individual one-hour sessions for 5 weeks,
supplemented by home practice, 30 minutes per day, 6 days per
week.
Koltai 2001: The group format consisted of five weekly, one-hour
sessions conducted in groups of four. The individual format con-
sisted of a mean of six individual sessions. Caregivers joined the
last 10 to 15 minutes of each session where available. As no differ-
ences were observed in results for group and individual training,
the data were analysed together.
Cahn-Weiner 2003: Weekly small-group sessions lasting 45 min-
utes each, over a 6-week period.
Loewenstein 2004: The interventions were delivered in 24 indi-
vidual sessions, each lasting 45 minutes over a 12- to 16-week pe-
riod.
Galante 2007: The intervention was delivered individually, with
each participant receiving twelve 60-minute sessions, three times
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a week, over 4 weeks,
Neely 2009: Participants were offered a one-hour session of home-
based training each week for a period of 8 weeks.
Clare 2010: Cognitive rehabilitation was delivered in eight weekly,
1-hour individual sessions conducted in participants’ homes.
Description of the comparison conditions
Beck 1988: Participants in the control condition received treat-
ment as usual with no additional intervention.
Heiss 1993: The social support condition consisted of weekly, one-
hour individual sessions that included conversation about personal
problems in managing daily life, as well as past experiences, some-
times assisted by games. It is not clear whether the sessions were
carried out individually or in groups.
Quayhagen 1995: Placebo intervention consisted of similar types
of caregiver-facilitated exercises, offered for an equivalent length
of time but designed to elicit only passive responses rather than
active processing and engagement.
de Vreese 1998: Participants received AChEImedication alone for
a 6-month period.
Quayhagen 2000: Wait-list control condition.
Davis 2001: ’Mock’ intervention involved five weekly, one-hour
individual sessions comprising unstructured conversation, recita-
tion of ’overlearned material’ and watching of health-related
videos.
Koltai 2001: Wait-list control condition.
Cahn-Weiner 2003: The comparison condition was an educa-
tional group intervention in which didactic information about
ageing and dementia was provided.
Loewenstein 2004: The mental stimulation intervention included
individual sessions comprising computer games, exercises like
’hangman’, word-finding tasks and discussion of the ’topic of the
day’.
Galante 2007: Participants in the nonspecific treatment condition
participated in a semi-structured interview on current affairs and
relevant events of their own life history. The neuropsychologist
who conducted the sessions made use of audiovisual material and
information received from participants and their relatives on the
participant’s life history, hobbies and favourite activities. The con-
trol condition was matched with the intervention group in terms
of number, duration and frequency of sessions.
Neely 2009: Participant dyads in the control condition did not
receive any intervention between the pretest and the post-test.
Clare 2010: Participants in the ’no treatment’ group had no con-
tact with the research team between baseline and post-interven-
tion assessments.
Excluded studies
Characterisitcs of excluded studies are summarised in the
Characteristics of excluded studies table.
Risk of bias in included studies
Risk of bias for individual studies, along with a justification for
our ratings, is summarised in tables under the Characteristics of
included studies section. Risk of bias for specific outcomes across
studies is summarised in Figure 2 and Figure 3.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Most studies had a low risk of bias in relation to random sequence
generation procedures, although lack of detail in four studies led
to difficulty in evaluating whether random sequence generation
was adequately performed. In addition, in all but two studies,
insufficient detail was provided to ascertain whether concealment
of the randomisation sequence was attempted.
Blinding
In most of the included studies (8/12), outcome assessments were
conducted by individuals described as blind to participants’ group
allocation. However, most studies were classified as high risk in
relation to blinding of participants and personnel. Although it is
recognised that blinding of participants and personnel is difficult
or impossible in trials of cognition-based interventions, researchers
can take steps to reduce the risk of bias due to lack of blinding of
participants and research personnel (Higgins 2011).
Incomplete outcome data
Six studies (50%) were classified as low risk as the result of incom-
plete outcome data, two studies were classified as high risk and the
remaining four were classified as unclear risk.
Selective reporting
Again, 6 of the 12 studies (50%) were classified as having low risk
of bias as the result of selective reporting, one studywas classified as
having a high risk of bias and the remaining five as having unclear
risk.
Effects of interventions
See: Summary of findings for the main comparison Cognitive
training compared to control in the short-term (i.e. immediately
post-intervention) for early-stage Alzheimer’s disease and vascular
dementia; Summary of findings 2 Cognitive rehabilitation
compared to control in the short-term (i.e. immediately post-
intervention) for early-stage Alzheimer’s disease and vascular
dementia
Cognitive training
Themeta-analysis revealed no differences between cognitive train-
ing and control conditions on any of the primary or secondary
outcomes included in the analyses (Data and analyses). Summary
of findings for themain comparison shows the results for a selected
number of central outcomes, and details of selected analyses of
interest are shown in Figure 4, Figure 5 and Figure 6. As can be
seen in the Summary of findings for the main comparison, longer-
term outcomes related to the trajectory of dementia (i.e. severity of
dementia, rates of admission to residential care) have not been as-
sessed in any of the included studies. Furthermore, evidence from
cognitive training interventions to date has been found to be of
low to moderate quality.
Figure 4. Forest plot of comparison: 13 Cognitive training vs control in the short term (immediately post-
intervention) outcome: 13.1 A1.1 Change in a global measure of cognition.
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Figure 5. Forest plot of comparison: 13 Cognitive training vs control in the short term (immediately post-
intervention) outcome: 13.13 B1.2 Change in participant’s mood (self-reported).
Figure 6. Forest plot of comparison: 13 Cognitive training vs control in the short term (immediately post-
intervention) outcome: 13.15 B1.4 Change in participant’s capacity for activities of daily living (Carer
reported).
Cognitive rehabilitation
Because only a single trial of cognitive rehabilitation (Clare 2010)
met criteria for inclusion in this review, no meta-analysis could
be conducted. Summary of findings 2 shows the results for a se-
lected number of important outcomes in Clare 2010. As can be
seen, cognitive rehabilitation was found to be superior to the con-
trol condition in the primary outcome of patient-reported im-
provement in goal performance over the short term as measured
by the Canadian Occupational Performance Measure (effect size
Z = 2.11, P = 0.04). Cognitive rehabilitation was also found to
be superior to the control condition in relation to outcomes not
shown in Summary of findings 2, Specifically, participants in the
cognitive rehabilitation group rated themselves as more satisfied
with their ability to carry out meaningful activities of daily liv-
ing compared with the control condition immediately following
the intervention, and they were more satisfied with their mem-
ory performance six months after the intervention compared with
the control group. A trend that approached significance suggested
that six months after the intervention, participants in the cogni-
tive rehabilitation group rated their overall quality of life as higher
than that of participants in the control condition (Clare 2010).
Evidence also indicated that caregivers of participants in the cog-
nitive rehabilitation group had improved social relationships after
the intervention relative to the control condition. Finally, in a sub-
set of participants who underwent functional neuroimaging with
fMRI while performing a learning task, cognitive rehabilitation
was associated with an increase in brain activation relative to the
control condition in the right fusiform face area the right medial
prefrontal cortex. In addition, although participants in the control
condition showed lower brain activation after the intervention in
the right parahippocampal cortex and in the right temporal pari-
etal junction, no reduction in brain activity in these regions was
noted for the group that underwent cognitive rehabilitation (Van
Paasschen 2013). As can be seen in the Characteristics of included
studies and Summary of findings 2, the evidence from Clare 2010
was generally regarded as of high quality. However, because the
evidence comes from a single study carried out in one setting with
a limited sample, the overall quality of evidence in relation to cog-
nitive rehabilitation is best described as moderate.
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D I S C U S S I O N
Summary of main results
The aim of this updated review was to evaluate current evidence
regarding the efficacy of cognitive training and cognitive rehabili-
tation interventions for people with mild AD or vascular demen-
tia. Eleven studies of cognitive training were identified for inclu-
sion in the review (nine of which were included in the previous
version of this review), and meta-analysis could be conducted on
8 primary and 6 secondary outcomes in the short term, and on 2
primary and 2 secondary outcome measures in the medium term.
No positive or adverse effects of cognitive training were detected
in the meta-analysis. The finding of no adverse effects of cognitive
training is relevant in light of proposals from previous commenta-
tors (e.g. Small 1997) that cognitive training may have a negative
impact, particularly on mood.
Only one RCT of individualised cognitive rehabilitation was iden-
tified (Clare 2010). Hence, no meta-analysis could be conducted.
Howevever, the results of this single, high-quality trial are positive,
indicating that cognitive rehabilitation is likely to provide some
benefit for patients in the short term and in the medium term
related to self-rated competence and satisfaction in performing
meaningful personal goals, memory capacity and general quality
of life.
Overall completeness and applicability of
evidence
Number of publications meeting inclusion criteria
Since the publication of the previous version of this review (Clare
2008), only two additional RCTs of cognitive training in partici-
pants with AD or vascular dementia were published that met the
review criteria (Galante 2007;Neely2009). In addition, only a sin-
gle studymet our inclusion criteria for individual cognitive rehabil-
itation (Clare 2010). Several factors appear to account for the small
number of new studies that met criteria for the present review.
First, insufficient methodological quality, namely, the absence of
randomisation, led to several published trials (e.g. Bentwich 2011;
Hwang 2012) not being included in the review. Second, several
RCTs of cognition-based interventions did not meet our defini-
tions of cognitive training and cognitive rehabilitation, or they
described multi-component interventions (e.g. Graff 2006; Kurz
2012). Issues related to the inclusion criteria used in the current
review are further discussed later. A third factor that may have
contributed to inclusion of a smaller number of relevant studies
in the literature is likely to be associated with the widely held be-
lief that interventions, pharmacological and non-pharmacological
alike, have the greatest chance of success when applied in the ear-
liest possible stage of AD or vascular dementia. Hence, in recent
years studies have increasingly targeted individuals who do not
meet criteria for dementia, but who nevertheless show significant
cognitive decline such as persons with amnestic mild cognitive
impairment (MCI) (Albert 2011; Gauthier 2006). Indeed, many
of the records that were retrieved in the updated literature search
now exclusively focus on individuals with MCI, and separate re-
views focusing on individuals with MCI are now available (Jean
2010 Martin 2011).
Issues related to the inclusion of RCTs only
The original protocol for the current review (Clare, Woods,
Moniz-Cook et al 2001) stated that only RCTs would be included
in the review. RCTs have been long regarded as the highest forms
of evidence in medical research because of the lower risk of bias
associated with them. However, most of the studies of cognitive
training included in the present review have been rated as having
substantial risk of bias in several domains, and the quality of evi-
dence has been found to be low to moderate. Low-quality RCTs
can in principle be associated with a greater threat to internal va-
lidity of the study than high-quality non-randomised trials and
even well conducted single-case studies. Hence, although more re-
cent studies are generally of a higher methodological quality, this
trend is likely to continue, it might be justifiable to include, under
strict conditions, high-quality non-randomised trials and single-
case studies in future versions of this review to increase the evi-
dence base from which conclusions can be drawn. Several possible
advantages are derived by including high-quality non-randomised
trials in a systematic review, and pooled estimates of effect sizes
from randomised and non-randomised trials can be analysed sep-
arately (Reeves 2011).
Issues related to definitions of interventions and multi-
component interventions
Despite progress in the application of a clearer and more con-
sistent terminology in referring to various cognition-based inter-
ventions in mild dementia, interventions often continue to be in-
accurately labelled. Specifically, studies continue to be published
in which interventions are described as cognitive training or as
cognitive rehabilitation, when in fact they appear to more closely
reflect cognitive stimulation or reality orientation (e.g. Giordano
2010). This state of affairs means that, in reviewing the available
literature and in choosing studies to include in the review, it was
generally insufficient to examine the title used in the publication,
and in many cases, the Methods section of a published trial had to
be closely scrutinised to clarify whether the intervention actually
provided was consistent with the one suggested by the title.
In addition, the present review excluded trials in which an inter-
vention was described as a combination of elements from various
approaches such as cognitive behaviour therapy combined with
elements of cognition-focused intervention (e.g. Kurz 2012). This
decision is related to the fact that different techniques are likely to
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have different mechanisms of action, and that it is generally not
possible with such interventions to isolate the contributions of dif-
ferent components to the measured outcomes. The definitions of
cognition-based interventions provided in this review essentially
reflect groups of intervention techniques that tend to go together,
but some overlap has been noted in the techniques used in cogni-
tive stimulation, training and rehabilitation (e.g. psychoeducation
may be a component of each of these approaches). Because each of
these broad approaches to intervention is likely to involve the use of
more than one intervention technique with different mechanisms
of action (e.g. setting goals, discovering effective ways to learn new
information, using repeated practice), these approaches can also
be regarded as essentially ‘multi-component’ interventions. Addi-
tional work is required to better characterise the essential or core
components of each of the broad approaches to intervention. It
is possible that inclusion of studies based on their use of discrete
intervention techniques (e.g. goal-setting, practice of structured
tasks, use of specific learning strategies such as errorless learning)
rather than on whether they neatly fit into the definitions offered
here might prove more informative.
Outcomes measured in included studies
A further issue influencing the completeness and applicability of
the evidence is the range of outcomes reported in the included
studies. Trials, particularly studies of cognitive training, have tra-
ditionally measured mainly cognitive outcomes in the form of
performance on standardised cognitive measures. Very few studies
have measured non-cognitive outcomes for the person with de-
mentia or for the primary caregiver (e.g. mood, quality of life, gen-
eral health and wellbeing) or longer-term outcomes that are likely
to be of critical importance to policy-makers, such as those related
to the course of dementia, for example, dementia severity and rates
of admission to residential care. Although obvious methodolog-
ical constraints are applied to the measurement of longer-term
outcomes, such as admission to residential care, it is nonetheless
important that future trials of cognition-based interventions, par-
ticularly those found to be effective, routinely measure and re-
port outcomes other than direct cognitive ones, and that attempts
are made to capture outcomes related to the future trajectory of
dementia. Given the nature and aims of individualised cognitive
rehabilitation interventions, these approaches tend to emphasize
individualised goals and activities of daily living over performance
on standardised cognitive tests. Indeed, the single trial of cogni-
tive rehabilitation included in the present reviewmeasured and re-
ported several important outcomes other than cognitive outcomes
that are of direct clinical relevance.
Methodological limitations of included studies
The lack of significant effects achieved in cognitive training stud-
ies must be interpreted in the context of methodological limita-
tions that may have constrained the possibility of demonstrating
significant gains, including issues related to power, choice of con-
trol condition and choice of outcome measures along with the
impact of individual characteristics that may moderate treatment
response.
Power to detect effects:Many of the included trials are likely to have
suffered from limited statistical power to detect effects. Lack of
power of individual studies to detect effects is commonly asso-
ciated with small sample sizes, which is a frequent limitation in
cognition-based interventions for people with mild AD and vas-
cular dementia. However, this explanation is unlikely to account
for the lack of significant findings, as a meta-analysis is designed
to overcome limitations derived from individual studies associated
with such factors as sample size. Indeed, not only was the size
of the effects in individual studies small, but, and this is possibly
of greater relevance, the direction of effects associated with some
outcomes did not consistently favour cognitive training over the
control condition. For example, in three out of five studies that
reported the impact of cognitive training on a global measure of
cognition in the short term, the direction of the effect favoured
the control group, whereas in only one of the trials did the effect
clearly favour the cognitive training condition (Figure 4). Indeed,
such inconsistency in the direction of effects was found to be the
case for a substantial number of outcomes reported by the stud-
ies, even when the same measures were used by different studies
to evaluate a given outcome. Other factors that might contribute
to the difficulty involved in detecting significant effects are diffi-
culties in determining the right ‘dose’ of an intervention (i.e. fre-
quency, intensity and duration of interventions), the presence of
’ceiling’ or ’floor’ effects, rendering it impossible to demonstrate
improvements in a given domain, and baseline differences between
treatment and control groups.
Choice of control condition: The difficulty of defining what consti-
tutes an appropriate comparison condition is particularly impor-
tant because in some studies (e.g.Cahn-Weiner 2003; Loewenstein
2004) cognitive training may have been compared with other ac-
tive treatments, thus masking potentially beneficial effects. Clini-
cal practice requires the ability to distinguish which of a range of
possible psychosocial interventions is most likely to be useful for
a given individual, and the study designs used here do not allow
this question to be addressed.
Use of neuropsychological tests as cognitive outcomes: The use of neu-
ropsychological tests to measure cognitive outcomes effectively
means that what is actually being assessed is transfer of benefit
from trained to untrained tasks, rather than the effects of training
on trained tasks. However, as was discussed in the introduction,
very limited evidence has been found to support such transfer ef-
fects from trained to untrained tasks. When the trained tasks are
analogous in some way to daily activities, however, improvement
in such tasks may have direct relevance to daily functioning, but
this would be missed if these benefits were not transferred to per-
formance on standardised neuropsychological tests. For example,
Davis 2001 noted improvement on tasks during training, such
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as recall of personal information and face-name associations, but
this was not captured by the neuropsychological measures selected
to assess cognitive outcomes. A further problem with the use of
standardised neuropsychological tests before and after the inter-
vention to measure cognitive outcomes involves the potential for
practice effects that may obscure possible effects of specific treat-
ments. Finally, in some studies, more than one neuropsychological
test or self-report scale is used to measure the same outcome (e.g.
executive function, general wellbeing). This leads to difficulties in
choosing which is the most appropriate or relevant measure of the
outcome under consideration for inclusion in the meta-analysis.
Moderating role of patient characteristics in intervention outcomes:
Investigators have learned that various patient characteristics have
the potential to moderate response to the intervention, and as
more evidence becomes available regarding importantmoderators,
cognition-focused interventions might be better able to control
for the effects of such moderators. For example, Koltai 2001 ret-
rospectively classified participants’ level of awareness of their own
impairments and found that a higher level of awareness was a pre-
dictor of a more successful outcome a finding that has also been
demonstrated in a prospective study of cognitive rehabilitation
outcomes for a small group of people with mild AD (Clare 2004).
The moderating impact of factors such as awareness of deficits
or the presence of neuropsychiatric symptoms (e.g. apathy) may
strengthen the rationale for inclusion of high-quality single-case
studies in future versions of this review.
Study context: Non-pharmacological studies are more likely than
drug trials to be affected by the study context, including the health-
care setting, as well as by cultural and linguistic factors. Given that
the studies reviewed have taken place in a variety of contexts, one
cannot exclude the possibility that cognition-based interventions
are better suited for some contexts than others.
Quality of the evidence
As has been discussed, the generally low methodological quality
of trials continues to limit the ability of researchers to evaluate
the evidence base. The quality of most of the studies of cognitive
training interventions included in the review was often compro-
mised by significant risks of bias particularly as a result of insuffi-
cient detail regarding themethod used to generate a random group
allocation sequence, concealment of this sequence from relevant
members of the research team and attempts to blind participants,
researchers or both to group allocation. Hence, the finding of no
significant benefit (or harm) from cognitive training interventions
needs to be interpreted with caution, and the estimate of effect
sizes may vary in the future as the evidence comes from studies
of greater quality. However, the methodological quality of trials
is gradually improving, and this trend is expected to continue in
coming years. Indeed, although only a single study of individu-
alised cognitive rehabilitation was identified, this study was rated
to be of high methodological quality and hence to have lower risk
of bias permitting the drawing of positive conclusions regarding
the efficacy of this approach. Although effect estimates that are
based on high-quality evidence are generally regarded as estimates
that are unlikely to change significantly with the publication of
further studies, confidence in the positive outcomes of cognitive
rehabilitation will nevertheless increase as evidence accumulates
from further high-quality, preferably multi-site, trials of cognitive
rehabilitation with larger sample sizes.
Agreements and disagreements with other
studies or reviews
In recent years, two main systematic reviews that included an ex-
amination of the efficacy of cognitive training for people with
mild dementia have been published. In reviewing the literature to
2004, Sitzer 2006 concluded that “cognitive training evidenced
promise in the treatment of AD,with primarilymediumeffect sizes
for learning, memory, executive functions, activities of daily liv-
ing, general cognitive problems, depression, and self-rated general
functioning”. Closer examination of the methodology described
in Sitzer 2006 reveals important differences that explain the in-
consistency in the results of the current review. First, Sitzer 2006
applied inclusion criteria that were much less strict and included
both randomised and non-randomised trials (total 19), as well as
studies that included participants with moderate to severe AD.
Second, although Sitzer 2006 described their review as a review of
cognitive training, of the 14 RCTs thatmet their inclusion criteria,
6 were in fact studies of other cognition-based interventions (pri-
marily reality orientation/cognitive stimulation) or multi-compo-
nent interventions. Indeed, in separate analyses, performed only
on the five “high-quality trials” (all of which were included in the
current review) the observed effects were very small and non-sig-
nificant. It is quite plausible that if studies of cognitive stimula-
tion, training and rehabilitation for people with mild AD or vas-
cular dementia were assessed together, some benefits would have
been detected. However, given the important differences among
the various cognition-focused approaches to intervention, these
should be treated separately. Indeed, although the current review
did not identify any benefits associated with cognitive training,
the results of a single, high-quality trial of cognitive rehabilitation
tentatively suggest that this approach may be associated with im-
portant benefits for the person with dementia and the primary
caregiver. In addition, a separate Cochrane review of cognitive
stimulation formild ADhas recently confirmed that this approach
was associated with several positive outcomes for the person with
dementia (Woods 2012).
More recently, Olazaran 2010 reviewed the general literature on
the efficacy of 26 categories of non-pharmacological interventions
for people with dementia. In relation to cognitive training, these
authors concluded that a Grade B recommendation (recommen-
dation associated with low-quality RCTs) can be given for the
efficacy of individual and group cognitive training in improving
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cognitive functions. No effects of cognitive training on other out-
comes were found. This conclusion seems to be different from that
of the current review, and important differences are evident be-
tween this review and that ofOlazaran 2010. Specifically,Olazaran
2010 included in their review participants with any kind of de-
mentia, and in fact allowed for inclusion of a small proportion
of participants with cognitive decline but without confirmed de-
mentia. In addition, like Sitzer 2006, Olazaran 2010 used less
strict inclusion criteria, leading to inclusion of several low-quality
studies. Finally, rather than examining different cognitive domains
separately, Olazaran 2010 analysed cognition broadly, and stud-
ies contributed diverse measures of cognition to the evaluation of
this outcome, whereas cognitive outcomes in the current study
were evaluated separately against widely agreed cognitive domains.
Thesemethodological differences aremost likely to account for the
differences between the current review and the review byOlazaran
2010.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Cognitive training: The review does not provide evidence to sup-
port the efficacy of cognitive training. Trial reports indicate that
some gains resulting from intervention may not be captured ade-
quately by available standardised outcome measures.
Cognitive rehabilitation:Data from a single, high-quality trial pro-
vide preliminary positive results regarding the use of contextu-
alised individual cognitive rehabilitation, emphasising collabora-
tive goal-setting to achieve better self-rated competence and satis-
faction with personally meaningful activities of daily living. Risk
of harm or adverse effects of cognitive rehabilitation are unlikely.
Given that the evidence to date comes from a single trial, the over-
all quality of evidence is best described as moderate. The capacity
to make firmer treatment recommendations awaits the publica-
tion of additional trials of individual cognitive rehabilitation.
Implications for research
Cognitive training: Further well-designed single-blind RCTs of
cognitive training would help to provide more definitive evidence
regarding efficacy. Future research would benefit from considera-
tion of how to capture changes that are currently missed by the
available standardised outcome measures, from development of
greater consensus in the selection of specific outcomemeasures and
from identification of the extent to which gains are clinically rele-
vant and generalisable, and have the potential to make a difference
for the person with dementia and the family caregiver in everyday
life. Future research should continue the trend towards devising
interventions that include personalised tasks or tasks based on ana-
logues of daily activities. Future research also needs to consider
outcomes beyond direct cognitive ones, to describe in greater de-
tail the elements of the intervention used (preferably using manu-
alised protocols) and to more accurately use existing classifications
of cognition-based interventions.
Cognitive rehabilitation: Additional RCTs of individualised cogni-
tive rehabilitation are needed to provide further support for ten-
tatively promising results.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by year of study]
Beck 1988
Methods RCT comparing cognitive training with a no-treatment control condition
Participants 20 participants with AD or mixed dementia and MMSE score of 15 to 20
Interventions • Cognitive skills remediation training: individual sessions three times a week for six
weeks.
• Control group.
Both groups continued to receive ’conventional’ treatment during the intervention
Outcomes Cognitive outcomes immediately post-intervention for the person with dementia were
reported in the domains of attention (letter cCancellation), memory (recall of numbers,
recall of details of a story) and visual perception (match-to-sample task). Differences in
favour of the experimental group found on one measure of memory (recall of digits)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The method of randomisation was not de-
scribed. Beck (personal communication)
indicates that the participants were ran-
domised using random number tables. The
equal number of participants in each group
suggests that block randomisation was used
Allocation concealment (selection bias) Unclear risk No allocation concealment procedures
were described.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data were available for all partic-
ipants.
Selective reporting (reporting bias) Low risk No selective reporting of data was noted.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants would have been aware of their
group allocation. No data were provided
regarding experimenter blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Assessments were conducted by assessors
who were not involved in the cognitive
training intervention. However, no infor-
mation was given to reveal whether out-
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Beck 1988 (Continued)
come assessments were conducted by asses-
sors blind to group allocation; therefore this
is unlikely to have been the case
Other bias Low risk No other significant sources of bias were
identified.
Heiss 1993
Methods RCT comparing four intervention conditions.
Participants 80 patients meeting NINCDS-ADRDA criteria for probable AD of mild to moderate
severity (MMSE 14 to 25). Data available for 70 of these
Interventions • Social support only (n = 17).
• Computerised cognitive training (CCT) covering memory and perceptual and
motor tasks in twice-weekly sessions (n = 18).
• Cognitive training plus pyritinol 2 × 600 mg/d (n = 17).
• Cognitive training plus phosphatidylserine 2 × 200 mg/d (n = 18).
Six months’ duration of treatment. For the purposes of this review, the CCT group was
compared with the social support group
Outcomes Cognitive outcomes for the participant immediately post-intervention were reported
in the domains of global cognition (MMSE), orientation, reaction time (Go/NoGo),
praxis, memory (verbal and visual selective reminding tasks), working memory (Corsi’s
Tapping Task), attention (concentration test for elderly people), language (verbal fluency,
token test), executive function, visual perception (Gorlin’s Incomplete Pictures Test)
and motor function (finger-tapping). Biomarker outcomes for the participant included
measures of brain activation (quantitative electroencephalogram (EEG) and FDG PET)
. Improved cognitive and brain activation outcomes were reported for the groups that
received cognitive training combined with pharmacological treatment
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The method of randomisation was not de-
scribed. Mielke (personal communication)
indicates that the method used was ’ran-
domisation by chance in blocks of four’
Allocation concealment (selection bias) Unclear risk No information was available.
Incomplete outcome data (attrition bias)
All outcomes
High risk Of the 80 participants who initially entered
the study, complete data were available for
only 70. It is not clear whether the attrition
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Heiss 1993 (Continued)
was evenly distributed between the studied
groups. The authors reported that the at-
trition was attributable to technical insuffi-
ciencies in the PET or EEG data, or to side
effects. Meilke (personal communication)
comments that the authors considered the
drop-out rate to be in the normal range for
clinical studies
Selective reporting (reporting bias) Unclear risk All relevant outcome data seem to have
been reported.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants in the two groups of interest
here would necessarily be aware of the in-
tervention condition to which they were al-
located. Whether research personnel were
blind to group allocationwas not indicated,
but it is unlikely that this was the case
Blinding of outcome assessment (detection
bias)
All outcomes
High risk The authors report that ’blinding was
not attempted since...the tedious blinding
procedures seemed unjustified in this ex-
ploratory pilot study’, but it is not clear
whether this refers to participants alone or
to both participants and assessors
Other bias Unclear risk No other significant sources of bias were
identified.
Quayhagen 1995
Methods RCT comparing cognitive training with placebo and wait-list control
Participants Out of 95 eligible families, 79 community-dwelling persons with mild to moderate AD
(scoring at least 90 on the Mattis Dementia Rating Scale) and their family caregiver
completed the intervention. Data were available for 78 of these (51 male and 27 female
patients; 18 male and 60 female caregivers)
Interventions • Experimental condition: one hour daily of cognitive training facilitated by
caregiver, using tasks covering memory, problem-solving and conversational fluency,
and weekly home visits by therapist (n = 25).
• Placebo (active) condition: passive observation of activities similar to tasks used in
experimental condition (n = 28).
• Wait-list control (n = 25).
For the purposes of the current review, the experimental condition was compared with
the wait-list control condition
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Quayhagen 1995 (Continued)
Outcomes Cognitive outcomes for person with dementia were reported immediately after the 12-
week intervention and at a 6-month follow-up in the domains of global cognition (Mat-
tis Dementia Rating Scale), memory (Logical Memory-I, Figural Memory, Visual Re-
production), language (letter and semantic fluency), problem-solving (Geriatric Coping
Measure), and attention (Block Span, Digit-Span). Non-cognitive outcomes for the per-
son with dementia included the Memory and Behaviour Problems Checklist (caregiver
reported). At the follow-up assessment, participants in the experimental condition were
at or around baseline on cognitive and behavioural measures, whereas the control group
showed further decline
Notes Comparison of the training programme with a shortened version used in subsequent
work is covered in Quayhagen & Quayhagen 2001.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The method of randomisation was not de-
scribed. Quayhagen (personal communi-
cation) advises that the method used was
’stratified randomisation across groupswith
the strata representing severity of dementia
as measured by the DRS’. The unit of ran-
domisation was the caregiver/care recipient
dyad, but randomisation was done on the
basis of the level of severity of dementia of
the care recipient
Allocation concealment (selection bias) Unclear risk No information was available to reveal
whether group allocations were concealed
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Out of 95 eligible families, 79 com-
pleted the nine-month project (83%). The
16 drop-outs were attributed mainly to
’non-project-related mortality or morbid-
ity’. One further family was excluded from
the analysis as the result of ’data inconsis-
tency’. The authors note that of 25 fam-
ilies in the wait-list control group, only
5 opted to take cognitive training at the
end of the waiting period. No information
was provided comparing participants who
completed the study with those who had
not
Selective reporting (reporting bias) High risk The authors declined to supplymean scores
on individual measures for use in this re-
view. Results were reported only for se-
lected outcome measures rather than for all
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Quayhagen 1995 (Continued)
measures identified in the Methods section
of the paper. It is possible, therefore, that
some non-significant results have not been
reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The placebo condition provided a control
for therapist attention and level of interac-
tion between caregiver and care recipient. It
is not clear, however, whether participants
were
aware of the condition to which they
were assigned. The authors note that some
members of the placebo group appeared
to initiate active processing of the tasks,
and this may have led to a confound be-
tween the two conditions. It is not clear
who exactly carried out the interventions
and whether the same individuals deliv-
ered interventions in the experimental and
placebo groups. It is unlikely that those car-
rying out the interventions were blinded to
group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessments were carried out by research
assistants who ’with rare exceptions’ were
blind to the condition
Other bias Unclear risk The authors did not provide baseline char-
acteristics for the cognitive training and
comparison groups, but the authors com-
mented that no differences were noted be-
tween the groups at baseline
de Vreese 1998
Methods RCT comparing three intervention groups with placebo control
Participants 24 patients with mild tomoderate AD (Clinical Dementia Rating score 1 to 2) according
to NINCDS-ADRDA criteria
Interventions • Acetylcholinesterase inhibitor (AChE-I) alone.
• Cognitive training in twice-weekly sessions lasting 45 minutes and targeting
memory, language and executive function, with home practice facilitated by caregiver,
for 3 months.
• AChE-I plus cognitive training (introduced after 3 months on drug).
• Placebo medication.
For the purposes of this review, the cognitive training plus acetylcholinesterase (AChE)
condition was compared with the AChE-I-only condition
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de Vreese 1998 (Continued)
Outcomes Cognitive outcomes for person with dementia were assessed in the domains of global
cognition (MMSE, Alzheimer’s Disease Assessment Scale, Cognitive subscale (ADAS-
Cog)). Non-cognitive outcome measures for the person with dementia were reported
in the domains of behaviour (Interview of Spontaneous Behaviour) and activities of
daily living (Instrumental Activities of Daily Living Scale). Benefits for both cognitive
and non-cognitive outcomes were observed in the group that received a combination of
AChE-I and cognitive training
Notes The authors state that the groups did not differ on demographic and baseline character-
istics. However, group-level data were not available
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The method of randomisation was not de-
scribed.
Allocation concealment (selection bias) Unclear risk Whether allocation concealment was at-
tempted was not described
Incomplete outcome data (attrition bias)
All outcomes
Low risk No mention is made of attrition.
Selective reporting (reporting bias) Unclear risk Published results were reported in terms
of change from baseline, but mean scores
for each assessment point were provided by
the author (de Vreese, personal communi-
cation)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were necessarily aware of
whether they were in the AChE-I plus cog-
nitive training group as opposed to AChE-
I alone (and this presumably also indicated
to them that they were receiving the active
drug and not the placebo). The compar-
ison does not incorporate any control for
therapist attention or other placebo effects
arising from the training condition. No in-
formation was provided regarding blinding
of experimental personnel
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors were blind to the condition.
Other bias Low risk No other significant sources of bias were
identified.
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Quayhagen 2000
Methods RCT comparing four treatment conditions with a wait-list control
Participants 103 persons (65 men, 38 women) with dementia (AD, vascular dementia or Parkinson’s
dementia) in the mild or moderate stage (scoring over 100 on the Mattis Dementia
Rating Scale), together with their spouse caregivers
Interventions • Cognitive stimulation (n = 21). Training on memory, problem-solving and
conversational fluency for one hour daily, 5 days a week, facilitated by spouse, with
support from therapist.
• Dyadic counselling (n = 29), focused on problem/conflict identification, stress
reduction, anger/frustration management, communication enhancement and conflict
resolution.
• Dual supportive seminar groups (n = 22). Initial meeting for both partners (1.5 h)
, followed by seven sessions including both separate (1 h) and joint (0.5 h) meetings for
patients and spouses, with discussion of specified topics.
• Early-stage day care (n = 16). Patients met for 4 hours per week to engage in
stimulating activities. Monthly support group for caregivers.
• Wait-list control (n = 15).
For the purposes of this review, cognitive training and wait-list control conditions were
compared
Outcomes Cognitive outcomes for the person with dementia were reported in the domains of mem-
ory (Logical Memory, Visual Reproduction), language (Verbal Fluency) and problem-
solving (Geriatric Coping Schedule). Non-cognitive outcomes for the person with de-
mentia were reported in the domain of behaviour (Memory and Behaviour Problems
Checklist, caregiver-rated)
Outcomes for caregiver were reported in the domains of marital satisfaction (Marital
Needs Satisfaction Scale), emotional status (Brief Symptom Inventory), morale (Geri-
atric Centre Morale Scale), physical health status (Health Assessment Scale), perceived
stress (Memory and Behaviour Problems Checklist, Part B), coping (Coping Strategies
Inventory Revised), social support (Social Support Questionnaire) and satisfaction with
intervention. Outcome for the course of the disease was measured using the Dementia
Rating Scale. The cognitive stimulation group had better cognitive outcomes at 3months
post-intervention. Caregivers of patients in this group had lower depressive symptoms
Notes Although the authors report in the article that treatment groups did not differ in terms of
age, education or racial distribution, demographic data were not provided at the group
level
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk As in the 1995 trial, the method of ran-
domisation was not described. Quayhagen
(personal communication) advised that the
method used was ’stratified randomisation
across groups with the strata representing
severity of dementia as measured by the
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Quayhagen 2000 (Continued)
DRS’. The unit of randomisation was the
caregiver/care recipient dyad, but randomi-
sation was done on the basis of the level of
severity of dementia of the care recipient
Allocation concealment (selection bias) Unclear risk No information was available to indicate
whether group allocations were concealed
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The participant sample reported appears
to include only those who completed the
study (n = 103), but the authors mention
in the discussion that attrition did occur,
and that this was higher in the early-stage
day care group, possibly because of trans-
portation issues.The authors also reported
that only 15 members of the wait-list con-
trol group agreed to proceed to their allo-
cated intervention after their waiting pe-
riod, which is the total number given for
the wait-list group in the analyses. No other
information was provided to clarify the risk
of attrition bias, but the relative lack of
change in most outcome measures within
the early-stage care group suggests that at-
trition may not have biased the results
Selective reporting (reporting bias) Low risk No evidence of selective data reporting was
noted.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were aware of the intervention
type to which they were allocated. It is not
clear whether the therapists contributed to
more than one intervention type
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors were blind to the condition to
which participants were randomly assigned
Other bias Unclear risk The authors did not provide baseline char-
acteristics for the cognitive training and
comparison groups, but the authors com-
mented that no differences were noted be-
tween the groups at baseline
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Davis 2001
Methods RCT comparing intervention and placebo in cross-over design: participants in placebo
condition crossed over to receive intervention
Participants 37 patients (16 men, 21 women) with probable AD and a mean (M) MMSE score of
22.78 (SD 4.45) for control, and M = 21.84 (SD 4.03) for intervention
Interventions Intervention condition: one hour of individual training weekly for five weeks on face-
name associations and recall using spaced retrieval, plus home practice (0.5 hours/d for
6 days/wk) on attention-training exercises.
Placebo condition: ’mock’ intervention consisting of one-hour clinic visit weekly for
unstructured conversation and questioning with examiner and viewing of health-related
videos
Outcomes Cognitive outcomes for the person with dementia were reported in the domains of
global cognitive functioning (MMSE), memory (Logical Memory, Visual Reproduction)
, working memory and attention (Digit-Span, Verbal Series Attention Test), language
(verbal fluency) and psychomotor ability (finger-tapping). Non-cognitive outcomes for
the personwith dementiawere reported in the domains of depressive symptoms (Geriatric
Depression Scale self-rated) and quality of life (Quality of Life Assessment rated by the
caregiver). Although participants in the cognitive training group improved in trained
measures, no differences between this and the control group were observed in any of the
untrained outcome measures
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The method of randomisation was not de-
scribed.
Allocation concealment (selection bias) Unclear risk The method of randomisation was not de-
scribed.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No attrition was reported for the initial
phase. However, four participants who ini-
tially received the placebo condition de-
cided to discontinue at the cross-over point
because of loss of interest in the trial. Be-
cause the analyses focused on the initial
group allocation (before the cross-over), at
which no participants were lost, risk of at-
trition bias was unlikely at this point
Selective reporting (reporting bias) Unclear risk The authors did not report the means and
SDs of the placebo group at the third time
point, that is, after they crossed over to re-
ceive the intervention. However, these data
were not required for the meta-analyses, as
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they focus only on the first phase (before
cross-over); therefore it is unlikely that se-
lective reporting would have introduced a
reporting bias into the analyses
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Once the intervention began, participants
were aware of which condition they were
receiving. It is not clear whether training
and placebo conditions were provided by
the same therapists, and it is not possible
to evaluate the likelihood of contamina-
tion between conditions. The placebo con-
dition, while controlling for length and du-
ration of clinic visits and therapist atten-
tion, did not provide a control for the use
of home practice
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors were blind to conditions at initial
and post-intervention assessments but not
at the third assessment point for the initial
placebo group after cross-over. Random se-
quence generation
Other bias High risk A trend towards differences favoured the
cognitive training group in baseline charac-
teristics that are likely to have an impact on
outcomes (age, education, anti-depressant
medication use)
Koltai 2001
Methods RCT comparing two intervention conditions and wait-list control
Participants 24 participants (22 completed the study) with mild/moderate dementia (scoring 0.5 to
1.0 on the Clinical Dementia Rating)
Interventions • Memory and coping programme in individual sessions, with a mean of 6 sessions
(n = 8).
• Memory and coping programme in group sessions (n = 8). Five, one-hour, weekly
sessions in groups of four.
• Wait-list control (n = 8). Participants received the intervention once all post-
intervention testing was complete for the other groups.
The programme included training and practice in strategies of spaced retrieval, face-
name recall, verbal elaboration, concentration/overt repetition, use of external memory
aids and ways of coping. Caregivers joined the last 10 to 15 minutes of each session
where available.
As no differences in outcome were found between individual and group formats, the
results for these two conditions were analysed together and were compared with those
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for the wait-list control group
Outcomes Cognitive outcomes for the person with dementia included global cognition (MMSE)
, memory (List Learning from the Consortium to Establish a Registry for Alzheimer’s
Disease test battery), language (abbreviated Boston Naming Test, Category Fluency)
, apraxia (Rosen Figures of Constructional Praxis) and perceived memory problems
(Everyday Memory Questionnaire self- and caregiver-rated). Non-cognitive outcomes
for the person with dementia included depressive symptoms (Geriatric Depression Scale
self- and caregiver-rated).
Trends favouring the cognitive training group were observed, but no comparison reached
statistical significance
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The method of randomisation was not de-
scribed. Koltai (personal communication)
indicated that randomisation was done by
roll of dice. Given the different sizes of the
two groups, simple (consecutive) randomi-
sation would have been used
Allocation concealment (selection bias) Unclear risk No data were available.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Two participants from the Memory and
Coping group did not complete the inter-
vention because of serious illness (8% at-
trition). It was not stated whether this se-
rious illness was related or unrelated to de-
mentia severity, and therefore it is not clear
whether these two patients would have had
poorer outcomes had they remained in the
study. If this had been the case, it may have
contributed to the appearance of the inter-
vention as more effective or of anosognosia
as having greater impact
Selective reporting (reporting bias) Low risk Raw data were not reported in the paper,
as data were reported in terms of change
from baseline scores. In addition, not all
measures that were included in the assess-
ment were reported in the results. Specif-
ically, the Boston Naming Test, Category
Fluency, and Rosen Figures were all in-
cluded in the assessment but were not re-
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ported in the results. Given that the authors
have stated that the intervention was not
effective in relation to objective cognitive
measures, it is assumed that no change was
observed on these measures as well
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were aware of their group al-
location. Koltai conducted all therapeutic
interventions and therefore would not have
been blinded to group allocation. Whether
other research personnel were blinded to
group allocation was not discussed
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Koltai (personal communication) con-
firmed that assessments were conducted
blind to the condition. Given that Koltai
conducted all interventions, it is not clear
who conducted the assessments
Other bias High risk Baseline imbalances between the groups
(favouring the control group) on a global
measure of cognition (MMSE) and on the
severity of depressive symptoms (rated by
the caregiver) may have biased the out-
comes
Cahn-Weiner 2003
Methods RCT comparing memory training with a no memory training control
Participants 34 participants with mild probable AD and a mean MMSE score of 25.1 (SD 1.7) for
control, and M = 24.3 (SD 2.2) for intervention
Interventions • Intervention group: memory training programme of six weeks’ duration to
improve word-list recall and recognition.
• Active control: control group received didactic presentations but no formal
memory training.
Outcomes Cognitive outcomes for the person with dementia immediately post-intervention and at
short-term follow-up were reported in the domains of global cognition (MMSE), mem-
ory (Hopkins Verbal Learning Test Revised, Brief Visuospatial Memory Test Revised)
, language (Boston Naming Test, Controlled Oral Word Association Test), executive
function (Trail Making Test), perception (Judgement of Line Orientation Test) and self-
and other-reported memory function (Everyday Memory Functioning). Non-cognitive
outcomes for the person with dementia immediately following the intervention and
at short-term follow-up included informant-reported ADLs (Instrumental Activities of
Daily Living and Physical Self-Maintenance Scale). No group differences were observed
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly assigned by
coin-toss. This type of simple randomisa-
tion tends to yield different group sizeswith
small samples (N < 100). Given that the in-
tervention and control groupswere of equal
size (n = 17), it is unlikely that simple ran-
domisation was used, and randomisation
was most likely done in blocks. In addition,
the authors state that the coin-toss was per-
formed at the time consent was obtained,
which would have been before the base-
line assessment. This approach is generally
more prone to bias thanwhen the randomi-
sation sequence is performed after baseline
assessment has been completed
Allocation concealment (selection bias) Unclear risk Coin-toss was performed at the time con-
sent was signed. However, the authors pro-
vided no detail regarding who performed
the coin-toss
Incomplete outcome data (attrition bias)
All outcomes
Low risk Five participants who were initially en-
rolled withdrew from the study because
of difficulties involving transportation to
the clinic. Three participants were from
the control group, and two were from the
cognitive training group. One of these at-
tended a single intervention session, and
the rest participated only in the baseline as-
sessment. Five participants were excluded
from all analyses. They had on average
scores on the MMSE that were 1 point
lower than those of the intervention groups
and 2 points lower than those of the con-
trol group. However, the similar number of
withdrawn participants in the two groups
and the fact that all reportedly withdrew
as the result of transportation problems are
likely to lead to low attrition bias
Selective reporting (reporting bias) Low risk No selective reporting of data was noted.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The authors report that participants and
family caregivers were unaware of which
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condition they had been assigned to. How-
ever, it is questionable whether blinding of
participants is genuinely possible in studies
of this kind. A neuropsychologist blinded
to the results of the baseline assessment
conducted both experimental and control
interventions
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk A psychometrist blind to group allocation
conducted the assessments at all three time
points. One participant was assessed at the
final time point by the group leader
Other bias Low risk No other significant sources of bias were
identified.
Loewenstein 2004
Methods RCT comparing cognitive training with placebo control.
Participants 44 participants meeting NINCDS-ADRDA criteria for dementia and on stable dose of
an AChE-I and with a mean baseline MMSE score of 24.5 (SD 4.5) for control and M
= 23.4 (SD 2.9) for intervention
Interventions • Cognitive rehabilitation training.
• Mental stimulation.
Outcomes Cognitive outcomes for the person with dementia were reported in the domains of
memory (List Learning from the CERAD battery, Logical Memory), attention and
working memory (Digit-Span), language (Category Fluency), executive function (Trail
MakingTest) and reported cognitive function (InformantQuestionnaire of theCognitive
Decline in the Elderly Scale, self- and caregiver-rated). Scores on measures analogous
to tasks used in the training sessions were also used (e.g. Face-Name Learning Task)
. Non-cognitive outcome measures for the person with dementia were reported in the
domains of behaviour (Revised Memory and Behaviour Problems Checklist, caregiver-
rated), activities of daily living (Bayer Activities of Daily Living Scale, self- and caregiver-
rated) and depressive symptoms (Centre for Epidemiological Studies Depression Scale)
Participants in the cognitive training group improved in their performance on tasks
analogous to the ones used during training to a greater extent than themental stimulation
group. No group differences were reported on any of the untrained tasks
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The method of randomisation was not de-
scribed
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Allocation concealment (selection bias) Low risk Loewenstein (personal communication)
indicates that randomisation was done by
envelope selection after baseline evaluation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Five participants three from the cognitive
training group and two from the mental
stimulation group were not included in
the statistical analyses because they did not
complete all the required sessions. No in-
formation was provided on whether these
sessions were intervention sessions or out-
come assessments, and no reasons for these
incomplete data were provided. Given the
small and similar rates of incomplete data
between groups, is it unlikely that this
would have introduced substantial attrition
bias
Selective reporting (reporting bias) Unclear risk No informationwas provided on themeans
and SDs of untrained cognitive tasks at the
various assessment points
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Two neuropsychologists trained an equal
number of participants in both treatment
groups and would have been therefore
aware of group allocation. Although not
explicitly stated, participants would have
known the group to which they were allo-
cated
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Baseline, post-intervention, and follow-
up assessments of all outcomes were con-
ducted by the same assessor, who was blind
to the treatment condition
Other bias Low risk No other significant sources of bias were
identified.
Galante 2007
Methods Single-blind RCT comparing the efficacy of computerised cognitive training (CT) versus
a no treatment (NT) condition
Participants 12 participants who met criteria for mild AD (according to NINCDS-ADRDA criteria,
with MMSE 19 to 26 or MODA 70 to 90) and who were treated with AChE-I for at
least 3 months
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Interventions • Computerised CT (n = 7): 12 individual 60-minute sessions, 3 times per week,
for 4 weeks. 15 computer tasks delivered using TNP software at a fixed order for all
participants.
• Active control: Participants in the control group (n = 4) participated in 12
individual 60-minute sessions, 3 times per week, for 4 weeks. Participants attended a
semi-structured interview on current affairs and relevant events of their own life history.
Outcomes Cognitive outcomes for the person with dementia were reported in the domains of
global cognition (MMSE, MODA), memory (prose memory), visual working memory
(Corsi’s Block Tapping), attention (digit cancellation task, Bisyllabic Word Repetition
Test), problem-solving (Raven’s Coloured Progressive Matrices), language (verbal flu-
ency) and constructional and ideomotor apraxia. Non-cognitive outcomes for the per-
son with dementia were reported in the domains of mood (Neuropsychiatric Inventory,
caregiver-rated; Geriatric Depression Scale, self-rated) and activities of daily living (Basic
and Instrumental Activities of Daily Living Scales). Investigators found that although
participants in the control group declined in terms of MMSE scores over the 9 months
of the study, participants receiving cognitive training remained stable by the end of the
study period
Notes No informationwas provided on the extent towhich the groupswerematched on relevant
variables before the intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were assigned to treatment or
control group by simple randomisation,
leading tounequal group sizes. Themethod
of randomisation was not described
Allocation concealment (selection bias) Unclear risk No data were available.
Incomplete outcome data (attrition bias)
All outcomes
High risk One participant, assigned to the control
condition, was “excluded from the study
for poor compliance”. It is not clear at
what point this participant was excluded
(i.e. before or after completion of the in-
tervention). Given that the control group
had only four participants, it is quite possi-
ble that exclusion of this participant would
have biased the results
Selective reporting (reporting bias) Low risk All relevant outcome data were reported.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No data were provided, but participants
would have been aware of their group allo-
cation
52Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Galante 2007 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Participants were evaluated by a neuropsy-
chologist blinded to patient group alloca-
tion
Other bias Unclear risk Separate details for the groups at baseline
were not provided. Visual inspection sug-
gests trends towards baseline imbalances on
cognitive and affective measures that are
likely to be related to outcomes. The signif-
icance of these trends is, however, unclear
Neely 2009
Methods RCT comparing collaborative CT (dyadic) with individual CT and no treatment control
Participants Participants with mild to moderate AD or vascular dementia (n = 47 couples invited to
participate, n = 30 agreed and randomly assigned), with a mean MMSE score of 18.6
(SD 5.7) for control and M = 22.9 (SD 4.1) for intervention
Interventions • Collaborative group: one hour per week of CT at home for 8 weeks. Caregiver
and the person with dementia together acquired and practised strategies to support
everyday mnemonic and occupational performance. CT focused on spaced retrieval,
which was used only in a face-name task, and hierarchical cueing, which was used in
both the table-setting activity and the face-name task.
• Individual CT: The person with dementia received the same training as the
collaborative group, with the exception that the training was conducted without any
involvement of the caregiver. The support strategies were instead provided by a research
assistant.
• Control condition: The control condition received no intervention between the
two assessments.
Outcomes Cognitive outcomes for the person with dementia were reported in the domain of mem-
ory (categorisable and non-categorisable word-list recall; random and clustered object
recall task)
Outcomes for caregiverwere reported in the domains of caregiver burden (ZaritCaregiver
Burden Interview) and depression (Beck Depression Inventory)
Notes Two treatment groups were compared in the study: collaborative (dyadic) CT and indi-
vidual CT. Outcomes included in the current review focus on the individual CT group.
No differences between the individual training group and the control group were ob-
served in any of the outcome measures
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk The authors state that the first 30 couples
to have consented for the study were ran-
domly assigned to the collaborative pro-
gramme, the individual programme, or the
control group. Given the equal number of
participants in each of the three groups,
randomisation would have been done in
blocks. No details on the method of ran-
domisation were provided
Allocation concealment (selection bias) Unclear risk No information is provided to allow assess-
ment of this risk of bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Missing data for one couple in the control
group were noted, but no reasons were pro-
vided, and data analysis included the re-
maining nine dyads. Given the small sam-
ple size (n = 10 per group), missing data
have the potential to bias the results
Selective reporting (reporting bias) Unclear risk The authors reported a main effect of
test occasion on caregiver-rated depression,
showing that across groups, an increase
in depression followed the intervention.
However, no detail is provided regarding an
interaction between group and time in re-
lation to depression, and unlike other mea-
sures, no means and SDs were provided
in the article. In addition, no means and
SDs were provided for the Zarit Caregiver
Burden Scale, but the authors reported no
main effect of caregiver burden. Whether
the authors assessed for an interaction be-
tween group and test occasion on caregiver
burden was not explicitly stated
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No information was provided in the arti-
cle.However, participants would have been
aware of their group allocation. In addi-
tion, although not stated explicitly, the per-
son or persons delivering the intervention
would have been aware of group allocation.
Support for this is found in the descrip-
tion of the individual training group: “..
.the training was conducted without any
involvement of the caregiver. Instead, the
support strategies were provided by a re-
search assistant, rather than by the spousal
caregiver”
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Blinding of outcome assessment (detection
bias)
All outcomes
High risk No information was provided by the au-
thors, and it is probable that no blinding
of outcome assessment was carried out
Other bias Unclear risk Data on baseline educational levels in the
two groups were not reported. It is not clear
whether differences existed that could bias
relevant outcomes
Clare 2010
Methods Single-blind RCT comparing cognitive rehabilitation (CR) with relaxation therapy (RT)
and with no treatment
Participants 69 people (28 men, 41 women) with mild AD (MMSE > 18).
Interventions • Cognitive rehabilitation: eight weekly individualised CR sessions focusing on
patient-derived personal goals. Sessions supported by components addressing practical
aids and strategies, techniques for learning new information, practice in maintaining
attention and techniques for stress management.
• Relaxation therapy: Participants received the same amount of therapist time as
CR and an equivalent level of between-session practise. In accordance with a structured
treatment protocol, participants were taught progressive muscle relaxation and
breathing exercises and were encouraged to implement these whenever they
experienced anxiety.
• No treatment: Participants had no contact with the research team between initial
and post-intervention assessment.
Outcomes Cognitive outcomes for the person with dementia were reported in the domains of
memory (Rivermead Behavioural Memory Test), language (verbal fluency), attention
(Map Search, Elevator Counting, Elevator Counting With Distraction) and perceived
memory functioning (Memory Awareness Rating Scale, self- and caregiver-rated). Non-
cognitive outcomes for the person with dementia were reported in the domains of goal
performance and satisfaction (CanadianOccupational PerformanceMeasure), functional
abilities (Independent Living Scale Health and Safety subset), mood (Hospital Anxiety
and Depression Scale) and quality of life (Quality of Life in Alzheimer’s Disease, self-
and caregiver-rated). fMRI was reported as a biomarker outcome for a subset of persons
with dementia
Outcomes of the caregiver were reported in the domains of quality of life (World Health
Organisation Quality of Life Assessment Short Version), general health (GeneralHealth
Questionnaire-12), mood (Hospital Anxiety and Depression Scale) and stress (Relatives’
Stress Scale)
Participants in the cognitive rehabilitation group have shown significant improvement
in their rating of goal performance and satisfaction, as well as increased or preserved
activation in several brain regions
Notes Clare 2010was the only study found in the search that satisfied the definitionof ’cognitive
rehabilitation’ used in this review. Therefore no meta-analysis of cognitive rehabilitation
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outcomes could be conducted
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was conducted by
an independent trials unit using a computer
algorithm and was stratified for gender, age
(up to 69 years vs 70 years and older), and
geographical location (western, central, or
eastern district of the catchment area).”
Allocation concealment (selection bias) Low risk Quote: “Participants’ details were passed
to the therapist, an experienced occupa-
tional therapist, who contacted the trials
unit to initiate randomisation. Thus, only
the therapist was aware of the identities of
the participants allocated to each condi-
tion.” Given the use of a centralised ran-
domisation procedure, allocation conceal-
ment was more than likely achieved
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data were not available for four
participants who either withdrew from the
study or died. Two of these participants
were allocated to the cognitive rehabilita-
tion group. An additional participant with-
drew from the relaxation therapy group,
and one participant from the control group
died. In addition, one participant who was
initially allocated to the cognitive rehabil-
itation group was later deemed to have
met criteria for mild cognitive impairment
rather than dementia and was therefore ex-
cluded from the study, but thiswas reported
in a separate publication. Given the small
quantity of incomplete data and the rela-
tively even spread, the results are not likely
to have been biased by incomplete data.
Given that the participant excluded from
the CR group as the result of a changed di-
agnosis had results in the same direction as
that reported for the CR group, his exclu-
sion is unlikely to have biased the results
Selective reporting (reporting bias) Low risk No evidence suggested selective reporting
of data.
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Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants would have been aware of the
group to which they were allocated, and
one therapist conducted all interventions
and was therefore not blinded to group al-
location.The study authorswere blinded to
participants’ group allocation (Clare, per-
sonal communication). Although the pri-
mary outcomemeasure in the study (Cana-
dian Occupational Performance Measure
(COPM)) is based on subjective ratings
of performance and satisfaction, and this
could therefore be biased by lack of par-
ticipant blinding, it is unlikely to have bi-
ased outcomes in the current study given
the substantial memory loss in this pop-
ulation, who would have not been able
to recall their previous ratings. Although
the therapist conducting the interventions
was not blinded, the authors state that
treatments were conducted using a “struc-
tured treatment protocol” and that “adher-
ence to therapy protocols was monitored
through supervision and review of session
and home-practice records”, thereby reduc-
ing the risk of bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All outcome assessments were conducted
by research personnel blinded to partici-
pant group allocation
Other bias Unclear risk No other significant sources of bias were
identified.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Anderson 2001 Not RCT.
Arkin 1997 Not RCT.
Barban 2012 Conference abstract.
Bentwich 2011 Not RCT.
Bernhardt 2002 Not RCT.
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Bottino 2005 Describes cognitive stimulation.
Breuil 1994 Describes cognitive stimulation.
Brinkmann 1982 Not RCT.
Brodaty 1989 Not RCT.
Brodaty 1997 Long-term outcome from Brodaty 1989 (see above).
Ceccato 2012 This study describes a cognition-based music therapy intervention. Music therapy is recognised as a separate
form of intervention; therefore it was decided that this study would best fit into a review of music therapy
interventions. An additional factor leading to the exclusion of this trial is that the type of dementia was not
specified, so it is not possible to verify that participants were diagnosed only with AD or vascular dementia
Chapman 2004 Describes cognitive stimulation.
Clare 2002 Not RCT.
Diesfeldt 1991 No standardised outcome measures employed; not available in English
Dunlosky 2003 Participant criteria not met.
Ermini Fuenfsch 1995 Not RCT.
Farina 2006 Not RCT.
Fernandez 2006 A single case study.
Fernandez-Calvo 2010 Article published in Spanish and seems to fit better with a cognitive stimulation approach
Forster 2011 Although participants with MCI underwent cognitive training, the intervention delivered to participants
with dementia was weighted much more toward cognitive stimulation
Gaugler 2011 The intervention is best described as a memory support group
Giordano 2010 Describes reality orientation. Not RCT.
Goudour 2011 Study not published in English.
Graessel 2011 The interventiondescribed in this study is amulti-component intervention that includedmotor stimulation,
practice in ADLs and cognitive stimulation. Hence, the active ingredients of the intervention cannot be
identified
Graff 2006 The study describes a multi-component intervention following an occupational therapy clinical guideline
Guenther 1991 Participant criteria not met.
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Haslam 2011 Not RCT.
Hwang 2012 Not RCT.
Israel 1987 Participant criteria not met.
Israel 1989 Participant criteria not met.
Jelcic 2012 Conference paper.
Jobe 2001 Participant criteria not met.
Kixmiller 2002 Not RCT.
Kurz 2012 The intervention was a structured, multi-component intervention that has previously been variously de-
scribed by the authors as ’cognitive resource-oriented therapy’ or as ’neuropsychologically informed be-
haviour therapy’. The intervention was said to draw on principles from psychotherapy and neurorehabili-
tation, and included a range of elements such as reminiscence, activity scheduling, use of memory aids and
coping skills for managing memory difficulties. Hence the active ingredients could not be separated out,
and the study was excluded
Lam 2010 Intervention was an individualised functional enhancement programme and did not meet criteria for CT
or CR
Mate-Kole 2007 Not RCT.
Mayer 2012 Single case study of attentionprocess training in an individual withCADASIL (cerebral autosomal dominant
arteriopathy with subcortical infarcts and leucoencephalopathy)
Onor 2007 Study protocol describes reality orientation and reminiscence therapy therefore not CT or CR
Oresnik 2008 Not RCT.
Panza 1996 Not RCT.
Raggi 2007 Not RCT.
Requena 2004 Describes cognitive stimulation.
Schreiber 1999 Not RCT.
Sheikh 1986 Participant criteria not met.
Spector 2003 Describes cognitive stimulation.
Talassi 2007 Not RCT.
Tarraga 2006 Describes cognitive stimulation.
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Van Tilborg 2011 Not RCT. Intervention does not appear to meet criteria for CT or CR
Viola 2011 The intervention was described as amulti-component intervention including elements of cognitive training,
physical activity and expressive activities. The active ingredients could not be separated, and the study was
excluded
Yesavage 1981 Not RCT.
Zarit 1982 Participant criteria not met.
Characteristics of ongoing studies [ordered by study ID]
ACTRN12611001173987
Trial name or title Effectiveness of self-management skills enhancing rehabilitation on patients with dementia and their spousal
caregivers
Methods Parallel group RCT, no blinding will be attempted.
Participants 160 patients with dementia and their spouses.
Interventions Separate group-based interventions for the person with dementia and the primary caregiver. Groups will meet
for four hours once a week for 8 weeks. Group sessions will focus on empowering patients, increasing the
sense of agency and developing strategies to enhance their self-management skills
Outcomes Primary outcomes only:
• Quality of life (assessed at baseline, 3 and 9 months post intervention).
• Caregivers’ quality of life (assessed at baseline and 3 and 9 months post-intervention).
• Caregivers’ sense of competence (assessed at baseline and 3 and 9 months post-intervention).
Starting date 10/11/2011.
Contact information Marja-Liisa Laakkonen
Helsinki Health Center
Laakso Hospital
P.O. Box 6600
00099 The City of Helsinki
e: marja-liisa.laakkonen@kolumbus.fi
Notes Study set in Helsinki, Finland. It is unlikely to meet criteria for the current review
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Trial name or title Goal-oriented cognitive Rehabilitation in Early-stage Alzheimer’s disease: multi-centre single-blind ran-
domised controlled Trial (GREAT)
Methods RCT of cognitive rehabilitation vs usual care.
Participants AD patients (MMSE 14 to 26). Target N = 480.
Interventions Participants will be randomised to cognitive rehabilitation or treatment as usual. The cognitive rehabilitation
intervention protocol will consist of 10 weekly sessions followed by four maintenance sessions spread over a
six-month period
Outcomes Bangor Goal-Setting Interview (Primary outcome measure to be assessed at three and nine months post-
randomisation)
Starting date 1/10/2012.
Contact information Mrs Aleksandra Kudlicka
Trial Manager
School of Psychology
Bangor University
Bangor, Gwynedd LL57 2AS, UK
a.kudlicka@bangor.ac.uk
Notes The trial is expected to conclude on 31/1/2017.
NCT01329484
Trial name or title Computerised personal interventions for Alzheimer’s patients
Methods RCT.
Participants N = 159 (estimated).
Interventions • Reminiscence therapy.
• Cognitive training.
• No treatment.
Outcomes Cognitive function measured by Mindstreams (NeuroTrax Corp, Bellaire, TX) computerised neuropsycho-
logical assessment instrument at baseline and at 1, 3 and 6 months post-intervention
Starting date March 2011.
Contact information Tzvi Dwolatzky, MD, Mental Health Center, Beer-Sheva, Israel
Notes
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NCT01689948
Trial name or title Alzheimer disease: Rehabilitation’s Intervention at Home (pré-MATAPA)
Methods
Participants Patients with AD or mixed dementia, living at home and with an available family caregiver (N = 30, estimated)
Interventions Experimental: home rehabilitation therapy 12 weekly rehabilitation sessions in the home
Outcomes Primary outcome: scores on instrumental activities of daily living (IADLs) at 27 weeks
Starting date September 2012.
Contact information Gilles BERRUT, Pr, e: gilles.berrut@chu-nantes.fr.
Notes
Vidovich 2011
Trial name or title Cognitive activity for the treatment of older adults with mild Alzheimer’s disease (AD)--PACE AD: study
protocol for a randomised controlled trial
Methods RCT.
Participants 128 community-dwelling men and women with probable AD.
Interventions (1) Participants with mild AD and their companions together. (2) Companions of participants with mild AD
alone. The intervention will consist of a twelve-week programme of cognitive stimulation. Seven weeks of
the programme will involve 90-minute group sessions delivered once per week; the remaining weeks of the
programme will involve structured home-based activities with telephone support
Outcomes The primary outcome measure of the study is the change from baseline in total score on the AlzheimerDisease
Assessment Scale Cognitive (ADAS-Cog). Secondary outcomes of interest include changes in health-related
quality of life, mood, memory, language, executive functions, independent living abilities and psychiatric
symptoms for participants with mild AD. Primary endpoints will be collected 13 and 26 weeks after the
baseline assessment
Starting date 1/1/2010.
Contact information Mandy Vidovich
Western Australia Centre for Health and Ageing (WACHA)
Level 6 Ainslie House
48 Murray Street
Perth WA 6000
vidovichm@meddent.uwa.edu.au
Notes It is not clear whether the described intervention is cognitive stimulation or cognitive training
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D A T A A N D A N A L Y S E S
Comparison 13. Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 A1.1 Change in a global measure
of cognition
6 173 Std. Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.21, 0.40]
2 A1.2 Change in orientation 2 79 Std. Mean Difference (IV, Fixed, 95% CI) 0.31 [-0.13, 0.76]
3 A1.3 Change in cognitive ability
(self-reported)
2 66 Std. Mean Difference (IV, Fixed, 95% CI) 0.25 [-0.24, 0.74]
4 A1.4 Change in cognitive ability
(carer reported)
3 100 Std. Mean Difference (IV, Fixed, 95% CI) 0.23 [-0.17, 0.63]
5 A2.1 Change in immediate
verbal memory scores
9 259 Std. Mean Difference (IV, Fixed, 95% CI) 0.12 [-0.13, 0.37]
6 A2.2 Change in delayed verbal
memory scores
3 103 Std. Mean Difference (IV, Fixed, 95% CI) 0.12 [-0.27, 0.51]
7 A2.3 Change in verbal memory
recognition scores
2 69 Std. Mean Difference (IV, Fixed, 95% CI) 0.26 [-0.22, 0.73]
8 A2.4 Change in executive
function (sequencing) scores
2 153 Mean Difference (IV, Fixed, 95% CI) 7.47 [-14.19, 29.14]
8.1 Change in scores on Trails
A
2 77 Mean Difference (IV, Fixed, 95% CI) 14.53 [-9.35, 38.41]
8.2 Change on Trails B 2 76 Mean Difference (IV, Fixed, 95% CI) -25.26 [-76.70, 26.
19]
9 A2.5 Change in verbal letter
fluency scores
3 82 Std. Mean Difference (IV, Fixed, 95% CI) -0.02 [-0.46, 0.42]
10 A2.6 Change in verbal category
fluency scores
4 127 Std. Mean Difference (IV, Fixed, 95% CI) 0.07 [-0.28, 0.42]
11 A2.7 Change in attention and
working memory scores
2 46 Mean Difference (IV, Fixed, 95% CI) -0.46 [-1.64, 0.72]
12 B1.1 Change in participant’s
capacity for activities of daily
living (self-reported)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 B1.2 Change in participant’s
mood (self-reported)
4 114 Std. Mean Difference (IV, Fixed, 95% CI) 0.03 [-0.34, 0.41]
14 B1.3 Change in participant’s
general quality of life (self-
report)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 B1.4 Change in participant’s
capacity for activities of daily
living (Carer reported)
4 107 Std. Mean Difference (IV, Fixed, 95% CI) 0.00 [-0.38, 0.38]
16 B1.5 Change in participant’s
mood (carer reported)
2 66 Std. Mean Difference (IV, Fixed, 95% CI) 0.11 [-0.38, 0.61]
17 B1.6 Change in participant’s
general quality of life (carer-
reported)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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18 C1.1 Change in rates of
admission to residential care
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 C1.2 Change in measures of
dementia severity
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 D1.1 Change in self-reported
mood (carer)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
21 D1.2 Change in self-reported
burden of care
2 80 Mean Difference (IV, Fixed, 95% CI) -1.16 [-9.67, 7.34]
22 D1.3 Change in self-reported
overall wellbeing and quality of
life
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
23 E1.1 Effect of cognitive
training on biomarker evidence
of brain function
1 35 Mean Difference (IV, Fixed, 95% CI) -0.94 [-3.67, 1.79]
23.1 Change in glucose
metabolism at rest (FDG PET)
1 35 Mean Difference (IV, Fixed, 95% CI) -0.94 [-3.67, 1.79]
23.2 Effects on glucose
metabolism at activation (FDG
PET task)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
24 E1.2 Effect of cognitive
training on biomarker measures
of neuropathology
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 14. Cognitive training vs. control in the medium-term (3 to 12 months post-intervention)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 A2.1.1 Change in a global
measure of cognition
2 61 Std. Mean Difference (IV, Fixed, 95% CI) 0.51 [-0.01, 1.02]
2 A2.1.2 Change in cognitive
ability (self-reported)
0 0 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 A2.1.3 Change in cognitive
ability (carer reported)
2 78 Std. Mean Difference (IV, Fixed, 95% CI) 0.00 [-0.44, 0.45]
4 A2.2.1 Change in immediate
verbal memory scores
3 89 Std. Mean Difference (IV, Fixed, 95% CI) -0.05 [-0.48, 0.37]
5 A2.2.2 Change in delayed verbal
memory scores
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 A2.2.3 Change in executive
function (sequencing) scores
2 153 Mean Difference (IV, Fixed, 95% CI) 9.38 [-9.88, 28.65]
6.1 Change in scores on Trails
A
2 77 Mean Difference (IV, Fixed, 95% CI) 12.62 [-7.98, 33.23]
6.2 Change on Trails B 2 76 Mean Difference (IV, Fixed, 95% CI) -13.13 [-67.45, 41.
19]
7 A2.2.4 Change in verbal letter
fluency scores
1 11 Std. Mean Difference (IV, Fixed, 95% CI) 0.05 [-1.18, 1.28]
8 A2..2.5Change in verbal
category fluency scores
1 11 Std. Mean Difference (IV, Fixed, 95% CI) -0.05 [-1.28, 1.18]
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9 A2.2.6 Change in attention and
working memory scores
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 B2.1 Change in participant’s
capacity for activities of daily
living (self-reported)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 B2.2 Change in participant’s
mood (self-reported)
1 11 Std. Mean Difference (IV, Fixed, 95% CI) -0.11 [-1.34, 1.12]
12 B2.3 Change in participant’s
general quality of life (self-
report)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 B2.4 Change in participant’s
capacity for activities of daily
living (Carer reported)
3 89 Std. Mean Difference (IV, Fixed, 95% CI) -0.04 [-0.46, 0.38]
14 B2.5 Change in participant’s
mood (carer reported)
0 0 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 B2.6 Change in participant’s
general quality of life (carer-
reported)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 C2.1 Change in rates of
admission to residential care
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 C2.2 Change in measures of
dementia severity
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 D2.1 Change in self-reported
mood
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 D2.2 Change in self-reported
burden of care
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 D2.3 Change in self-reported
overall wellbeing and quality of
life
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
21 E2.1 Effect of cognitive
training on biomarker evidence
of brain function
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
21.1 Change in glucose
metabolism at rest (FDG PET)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
21.2 Effects on glucose
metabolism at activation (FDG
PET task)
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
22 E2.2 Effect of cognitive
training on biomarker measures
of neuropathology
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 13.1. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 1 A1.1 Change in a global measure of cognition.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 1 A1.1 Change in a global measure of cognition
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Davis 2001 19 0.16 (5.82) 18 0.22 (5.86) 22.0 % -0.01 [ -0.65, 0.63 ]
de Vreese 1998 9 5.24 (15.03) 9 -1.73 (21.12) 10.5 % 0.36 [ -0.57, 1.30 ]
Galante 2007 7 0.1 (4.98) 4 1.8 (3.33) 5.9 % -0.35 [ -1.59, 0.90 ]
Heiss 1993 18 -1.22 (8.13) 17 -1.04 (7.18) 20.8 % -0.02 [ -0.69, 0.64 ]
Koltai 2001 14 -0.21 (2.9) 8 0.75 (2.4) 11.9 % -0.34 [ -1.21, 0.54 ]
Quayhagen 1995 25 3.3 (16.76) 25 -4.4 (18.16) 29.0 % 0.43 [ -0.13, 1.00 ]
Total (95% CI) 92 81 100.0 % 0.10 [ -0.21, 0.40 ]
Heterogeneity: Chi2 = 3.36, df = 5 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 0.62 (P = 0.53)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours control Favours cog training
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Analysis 13.2. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 2 A1.2 Change in orientation.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 2 A1.2 Change in orientation
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Heiss 1993 18 0.6 (3.11) 17 -0.02 (3.28) 45.2 % 0.19 [ -0.47, 0.85 ]
Loewenstein 2004 25 0.96 (2.3) 19 -0.21 (3.25) 54.8 % 0.42 [ -0.19, 1.02 ]
Total (95% CI) 43 36 100.0 % 0.31 [ -0.13, 0.76 ]
Heterogeneity: Chi2 = 0.25, df = 1 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 1.38 (P = 0.17)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours control Favours cog training
Analysis 13.3. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 3 A1.3 Change in cognitive ability (self-reported).
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 3 A1.3 Change in cognitive ability (self-reported)
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Koltai 2001 14 6.43 (14.3) 8 1 (14.1) 31.7 % 0.37 [ -0.51, 1.24 ]
Loewenstein 2004 25 15.84 (22.19) 19 11.47 (21.97) 68.3 % 0.19 [ -0.40, 0.79 ]
Total (95% CI) 39 27 100.0 % 0.25 [ -0.24, 0.74 ]
Heterogeneity: Chi2 = 0.10, df = 1 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 0.99 (P = 0.32)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours cog training
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Analysis 13.4. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 4 A1.4 Change in cognitive ability (carer reported).
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 4 A1.4 Change in cognitive ability (carer reported)
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cahn-Weiner 2003 17 -4.8 (36.98) 17 6.6 (38.5) 35.4 % -0.29 [ -0.97, 0.38 ]
Koltai 2001 14 3.54 (14.7) 8 -5.75 (10.4) 20.2 % 0.67 [ -0.23, 1.56 ]
Loewenstein 2004 25 15.95 (30.56) 19 3.71 (20.82) 44.4 % 0.45 [ -0.16, 1.05 ]
Total (95% CI) 56 44 100.0 % 0.23 [ -0.17, 0.63 ]
Heterogeneity: Chi2 = 3.74, df = 2 (P = 0.15); I2 =46%
Test for overall effect: Z = 1.12 (P = 0.26)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours control Favours cog training
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Analysis 13.5. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 5 A2.1 Change in immediate verbal memory scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 5 A2.1 Change in immediate verbal memory scores
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Beck 1988 10 1.1 (2.77) 10 0.8 (3.78) 7.9 % 0.09 [ -0.79, 0.96 ]
Cahn-Weiner 2003 17 -0.4 (5.9) 17 -1.7 (5.71) 13.4 % 0.22 [ -0.46, 0.89 ]
Davis 2001 19 1.43 (7.78) 18 -0.22 (8.16) 14.6 % 0.20 [ -0.44, 0.85 ]
Galante 2007 7 -0.2 (11.81) 4 1.2 (17.14) 4.0 % -0.09 [ -1.32, 1.14 ]
Heiss 1993 18 0.41 (2.07) 17 0.09 (4.77) 13.9 % 0.09 [ -0.58, 0.75 ]
Koltai 2001 14 0.64 (1.7) 8 1.63 (2.8) 7.9 % -0.44 [ -1.32, 0.44 ]
Loewenstein 2004 25 -1.44 (15.84) 19 -0.64 (14.49) 17.1 % -0.05 [ -0.65, 0.55 ]
Neely 2009 10 0 (3.22) 10 -0.6 (2.42) 7.9 % 0.20 [ -0.68, 1.08 ]
Quayhagen 2000 21 2.79 (5.62) 15 -0.73 (6.68) 13.3 % 0.57 [ -0.11, 1.24 ]
Total (95% CI) 141 118 100.0 % 0.12 [ -0.13, 0.37 ]
Heterogeneity: Chi2 = 3.86, df = 8 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.96 (P = 0.33)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours control Favours cog training
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Analysis 13.6. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 6 A2.2 Change in delayed verbal memory scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 6 A2.2 Change in delayed verbal memory scores
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Davis 2001 19 1.15 (6.4) 18 1.65 (6.65) 37.1 % -0.08 [ -0.72, 0.57 ]
Koltai 2001 14 0.64 (1.3) 8 -0.25 (1.8) 19.6 % 0.57 [ -0.32, 1.46 ]
Loewenstein 2004 25 -0.16 (11.84) 19 -1 (8.07) 43.3 % 0.08 [ -0.52, 0.68 ]
Total (95% CI) 58 45 100.0 % 0.12 [ -0.27, 0.51 ]
Heterogeneity: Chi2 = 1.37, df = 2 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 0.59 (P = 0.55)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours control Favours cog training
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Analysis 13.7. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 7 A2.3 Change in verbal memory recognition scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 7 A2.3 Change in verbal memory recognition scores
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cahn-Weiner 2003 17 -0.4 (4.17) 17 -1.3 (4.46) 49.5 % 0.20 [ -0.47, 0.88 ]
Heiss 1993 18 0.9 (2.02) 17 0.17 (2.52) 50.5 % 0.31 [ -0.35, 0.98 ]
Total (95% CI) 35 34 100.0 % 0.26 [ -0.22, 0.73 ]
Heterogeneity: Chi2 = 0.05, df = 1 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 1.07 (P = 0.28)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours control Favours cog training
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Analysis 13.8. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 8 A2.4 Change in executive function (sequencing) scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 8 A2.4 Change in executive function (sequencing) scores
Study or subgroup Cogntive training Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Change in scores on Trails A
Cahn-Weiner 2003 17 5.2 (45.6) 17 -9.6 (54.54) 41.1 % 14.80 [ -18.99, 48.59 ]
Loewenstein 2004 24 1.96 (23.09) 19 -12.3 (72.22) 41.2 % 14.26 [ -19.50, 48.02 ]
Subtotal (95% CI) 41 36 82.3 % 14.53 [ -9.35, 38.41 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 1.19 (P = 0.23)
2 Change on Trails B
Cahn-Weiner 2003 17 6 (114.96) 17 33.3 (96.36) 9.2 % -27.30 [ -98.61, 44.01 ]
Loewenstein 2004 23 -16.78 (124.04) 19 6.26 (120.79) 8.5 % -23.04 [ -97.33, 51.25 ]
Subtotal (95% CI) 40 36 17.7 % -25.26 [ -76.70, 26.19 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.96 (P = 0.34)
Total (95% CI) 81 72 100.0 % 7.47 [ -14.19, 29.14 ]
Heterogeneity: Chi2 = 1.90, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Chi2 = 1.89, df = 1 (P = 0.17), I2 =47%
-100 -50 0 50 100
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Analysis 13.9. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 9 A2.5 Change in verbal letter fluency scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 9 A2.5 Change in verbal letter fluency scores
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cahn-Weiner 2003 17 0.3 (3.97) 17 1 (9.89) 42.0 % -0.09 [ -0.76, 0.58 ]
Davis 2001 19 0.22 (17.1) 18 1.33 (19.85) 45.7 % -0.06 [ -0.70, 0.59 ]
Galante 2007 7 3.5 (10.87) 4 -1.7 (16.91) 12.3 % 0.36 [ -0.88, 1.60 ]
Total (95% CI) 43 39 100.0 % -0.02 [ -0.46, 0.42 ]
Heterogeneity: Chi2 = 0.42, df = 2 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 0.09 (P = 0.93)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
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Analysis 13.10. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 10 A2.6 Change in verbal category fluency scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 10 A2.6 Change in verbal category fluency scores
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Davis 2001 19 1.84 (8.52) 18 1.06 (7.86) 29.7 % 0.09 [ -0.55, 0.74 ]
Galante 2007 7 0 (5.47) 4 0.1 (8.58) 8.2 % -0.01 [ -1.24, 1.21 ]
Heiss 1993 18 1.66 (7.25) 17 -1.07 (6.57) 27.5 % 0.38 [ -0.28, 1.05 ]
Loewenstein 2004 25 -1.32 (14.03) 19 1.22 (14.28) 34.6 % -0.18 [ -0.77, 0.42 ]
Total (95% CI) 69 58 100.0 % 0.07 [ -0.28, 0.42 ]
Heterogeneity: Chi2 = 1.53, df = 3 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.40 (P = 0.69)
Test for subgroup differences: Not applicable
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Analysis 13.11. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 11 A2.7 Change in attention and working memory scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 11 A2.7 Change in attention and working memory scores
Study or subgroup Cogntive training Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Galante 2007 7 0.1 (1.42) 4 0.7 (2.59) 18.4 % -0.60 [ -3.35, 2.15 ]
Heiss 1993 18 -0.28 (1.56) 17 0.15 (2.29) 81.6 % -0.43 [ -1.74, 0.88 ]
Total (95% CI) 25 21 100.0 % -0.46 [ -1.64, 0.72 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Not applicable
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Analysis 13.13. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 13 B1.2 Change in participant’s mood (self-reported).
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 13 B1.2 Change in participant’s mood (self-reported)
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Davis 2001 19 0.32 (3.36) 18 0.17 (9.83) 33.8 % 0.02 [ -0.62, 0.66 ]
Galante 2007 7 0.5 (2.05) 4 -0.3 (1.64) 9.1 % 0.38 [ -0.86, 1.62 ]
Koltai 2001 14 1.21 (2.5) 8 -0.13 (3) 18.0 % 0.48 [ -0.40, 1.36 ]
Loewenstein 2004 25 0.96 (13.27) 19 4.37 (13.79) 39.1 % -0.25 [ -0.85, 0.35 ]
Total (95% CI) 65 49 100.0 % 0.03 [ -0.34, 0.41 ]
Heterogeneity: Chi2 = 2.13, df = 3 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 0.16 (P = 0.87)
Test for subgroup differences: Not applicable
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Analysis 13.15. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 15 B1.4 Change in participant’s capacity for activities of daily living (Carer reported).
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 15 B1.4 Change in participant’s capacity for activities of daily living (Carer reported)
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cahn-Weiner 2003 17 0.2 (7.07) 17 0 (6.86) 32.4 % 0.03 [ -0.64, 0.70 ]
de Vreese 1998 9 1.33 (9.78) 9 -1.11 (7.52) 17.0 % 0.27 [ -0.66, 1.20 ]
Galante 2007 7 -0.6 (3.04) 4 0.5 (1) 9.4 % -0.39 [ -1.64, 0.85 ]
Loewenstein 2004 25 -0.6 (2.7) 19 -0.5 (2.41) 41.2 % -0.04 [ -0.63, 0.56 ]
Total (95% CI) 58 49 100.0 % 0.00 [ -0.38, 0.38 ]
Heterogeneity: Chi2 = 0.72, df = 3 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Not applicable
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Analysis 13.16. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 16 B1.5 Change in participant’s mood (carer reported).
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 16 B1.5 Change in participant’s mood (carer reported)
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Koltai 2001 14 1.62 (4.4) 8 1.38 (4.1) 32.1 % 0.05 [ -0.82, 0.92 ]
Loewenstein 2004 25 1.19 (11.88) 19 -0.67 (14.29) 67.9 % 0.14 [ -0.46, 0.74 ]
Total (95% CI) 39 27 100.0 % 0.11 [ -0.38, 0.61 ]
Heterogeneity: Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
Test for subgroup differences: Not applicable
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Analysis 13.21. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 21 D1.2 Change in self-reported burden of care.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 21 D1.2 Change in self-reported burden of care
Study or subgroup Cogntive training Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Loewenstein 2004 25 0.63 (20.31) 19 1.83 (13.94) 70.5 % -1.20 [ -11.33, 8.93 ]
Quayhagen 2000 21 -1.34 (19.34) 15 -0.26 (26.3) 29.5 % -1.08 [ -16.75, 14.59 ]
Total (95% CI) 46 34 100.0 % -1.16 [ -9.67, 7.34 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 0.27 (P = 0.79)
Test for subgroup differences: Not applicable
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Analysis 13.23. Comparison 13 Cognitive training vs. control in the short-term (immediately post-
intervention), Outcome 23 E1.1 Effect of cognitive training on biomarker evidence of brain function.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 13 Cognitive training vs. control in the short-term (immediately post-intervention)
Outcome: 23 E1.1 Effect of cognitive training on biomarker evidence of brain function
Study or subgroup Cogntive training Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Change in glucose metabolism at rest (FDG PET)
Heiss 1993 18 28.77 (5.03) 17 29.71 (3) 100.0 % -0.94 [ -3.67, 1.79 ]
Subtotal (95% CI) 18 17 100.0 % -0.94 [ -3.67, 1.79 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
2 Effects on glucose metabolism at activation (FDG PET task)
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 18 17 100.0 % -0.94 [ -3.67, 1.79 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
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Analysis 14.1. Comparison 14 Cognitive training vs. control in the medium-term (3 to 12 months post-
intervention), Outcome 1 A2.1.1 Change in a global measure of cognition.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 14 Cognitive training vs. control in the medium-term (3 to 12 months post-intervention)
Outcome: 1 A2.1.1 Change in a global measure of cognition
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Galante 2007 7 -1.5 (4.9) 4 -4.7 (3.41) 16.3 % 0.66 [ -0.62, 1.93 ]
Quayhagen 1995 25 -2.2 (19.29) 25 -12.6 (23.34) 83.7 % 0.48 [ -0.08, 1.04 ]
Total (95% CI) 32 29 100.0 % 0.51 [ -0.01, 1.02 ]
Heterogeneity: Chi2 = 0.06, df = 1 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 1.93 (P = 0.054)
Test for subgroup differences: Not applicable
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Analysis 14.3. Comparison 14 Cognitive training vs. control in the medium-term (3 to 12 months post-
intervention), Outcome 3 A2.1.3 Change in cognitive ability (carer reported).
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 14 Cognitive training vs. control in the medium-term (3 to 12 months post-intervention)
Outcome: 3 A2.1.3 Change in cognitive ability (carer reported)
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cahn-Weiner 2003 17 -2 (35.86) 17 -1 (43.07) 44.1 % -0.02 [ -0.70, 0.65 ]
Loewenstein 2004 25 6.14 (28.18) 19 5.5 (23.39) 55.9 % 0.02 [ -0.57, 0.62 ]
Total (95% CI) 42 36 100.0 % 0.00 [ -0.44, 0.45 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours control Favours cog training
80Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 14.4. Comparison 14 Cognitive training vs. control in the medium-term (3 to 12 months post-
intervention), Outcome 4 A2.2.1 Change in immediate verbal memory scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 14 Cognitive training vs. control in the medium-term (3 to 12 months post-intervention)
Outcome: 4 A2.2.1 Change in immediate verbal memory scores
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cahn-Weiner 2003 17 -1.1 (5.6) 17 -1.1 (6.18) 39.5 % 0.0 [ -0.67, 0.67 ]
Galante 2007 7 -11 (16.26) 4 3.7 (15.03) 10.5 % -0.85 [ -2.15, 0.46 ]
Loewenstein 2004 25 -0.36 (16.26) 19 -1.53 (15.75) 50.1 % 0.07 [ -0.53, 0.67 ]
Total (95% CI) 49 40 100.0 % -0.05 [ -0.48, 0.37 ]
Heterogeneity: Chi2 = 1.61, df = 2 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.25 (P = 0.81)
Test for subgroup differences: Not applicable
-0.5 -0.25 0 0.25 0.5
Favours control Favours cog training
81Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 14.6. Comparison 14 Cognitive training vs. control in the medium-term (3 to 12 months post-
intervention), Outcome 6 A2.2.3 Change in executive function (sequencing) scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 14 Cognitive training vs. control in the medium-term (3 to 12 months post-intervention)
Outcome: 6 A2.2.3 Change in executive function (sequencing) scores
Study or subgroup Cogntive training Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Change in scores on Trails A
Cahn-Weiner 2003 17 11.7 (40.25) 17 -1.4 (48.24) 41.6 % 13.10 [ -16.77, 42.97 ]
Loewenstein 2004 24 -1.13 (28) 19 -13.32 (58.19) 45.8 % 12.19 [ -16.27, 40.65 ]
Subtotal (95% CI) 41 36 87.4 % 12.62 [ -7.98, 33.23 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 1.20 (P = 0.23)
2 Change on Trails B
Cahn-Weiner 2003 17 3 (104.78) 17 28.8 (128.72) 6.0 % -25.80 [ -104.70, 53.10 ]
Loewenstein 2004 23 -0.56 (125.16) 19 1.16 (121.68) 6.6 % -1.72 [ -76.62, 73.18 ]
Subtotal (95% CI) 40 36 12.6 % -13.13 [ -67.45, 41.19 ]
Heterogeneity: Chi2 = 0.19, df = 1 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.47 (P = 0.64)
Total (95% CI) 81 72 100.0 % 9.38 [ -9.88, 28.65 ]
Heterogeneity: Chi2 = 0.95, df = 3 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Chi2 = 0.76, df = 1 (P = 0.38), I2 =0.0%
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Analysis 14.7. Comparison 14 Cognitive training vs. control in the medium-term (3 to 12 months post-
intervention), Outcome 7 A2.2.4 Change in verbal letter fluency scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 14 Cognitive training vs. control in the medium-term (3 to 12 months post-intervention)
Outcome: 7 A2.2.4 Change in verbal letter fluency scores
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Galante 2007 7 1 (10.75) 4 0.3 (16.91) 100.0 % 0.05 [ -1.18, 1.28 ]
Total (95% CI) 7 4 100.0 % 0.05 [ -1.18, 1.28 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
Test for subgroup differences: Not applicable
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Analysis 14.8. Comparison 14 Cognitive training vs. control in the medium-term (3 to 12 months post-
intervention), Outcome 8 A2..2.5Change in verbal category fluency scores.
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 14 Cognitive training vs. control in the medium-term (3 to 12 months post-intervention)
Outcome: 8 A2..2.5Change in verbal category fluency scores
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Galante 2007 7 -0.5 (4.32) 4 -0.2 (7.97) 100.0 % -0.05 [ -1.28, 1.18 ]
Total (95% CI) 7 4 100.0 % -0.05 [ -1.28, 1.18 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
Test for subgroup differences: Not applicable
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Analysis 14.11. Comparison 14 Cognitive training vs. control in the medium-term (3 to 12 months post-
intervention), Outcome 11 B2.2 Change in participant’s mood (self-reported).
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 14 Cognitive training vs. control in the medium-term (3 to 12 months post-intervention)
Outcome: 11 B2.2 Change in participant’s mood (self-reported)
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Galante 2007 7 -0.1 (2.86) 4 0.2 (1.12) 100.0 % -0.11 [ -1.34, 1.12 ]
Total (95% CI) 7 4 100.0 % -0.11 [ -1.34, 1.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.86)
Test for subgroup differences: Not applicable
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Analysis 14.13. Comparison 14 Cognitive training vs. control in the medium-term (3 to 12 months post-
intervention), Outcome 13 B2.4 Change in participant’s capacity for activities of daily living (Carer reported).
Review: Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia
Comparison: 14 Cognitive training vs. control in the medium-term (3 to 12 months post-intervention)
Outcome: 13 B2.4 Change in participant’s capacity for activities of daily living (Carer reported)
Study or subgroup Cogntive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cahn-Weiner 2003 17 -0.6 (6.93) 17 0.5 (7.45) 39.0 % -0.15 [ -0.82, 0.52 ]
Galante 2007 7 -0.7 (3.18) 4 0.3 (0.78) 11.5 % -0.35 [ -1.59, 0.89 ]
Loewenstein 2004 25 -0.8 (2.62) 19 -1.1 (2.8) 49.6 % 0.11 [ -0.49, 0.71 ]
Total (95% CI) 49 40 100.0 % -0.04 [ -0.46, 0.38 ]
Heterogeneity: Chi2 = 0.58, df = 2 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 0.20 (P = 0.84)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Summary characteristics of participants in cognitive training and control groups
Study Condition n
(completed
baseline as-
sessment)
Age mean
(SD),
range
Gender bal-
ance (m:f )
Years of ed-
ucation
Num-
ber taking
AChE-I
Baseline
MMSE
score
Discon-
tinue rates
Beck 1988 Cognitive
training
10 74 (range
68-75)
5:5 Attended
college = 2
none not reported 0
Control 10 76 (range
70-93)
3:7 Attended
college = 1
none not reported 0
Heiss 1993 Cognitive
training
not reported
(18
completed
the study)
65.9 (6.28) 9:9 not reported none 20.55 (4.42) not reported
Control not reported
(17
completed
the study)
66.6 (10.17) 10:7 not reported none 20.23 (4.10) not reported
Quayhagen
1995
Cognitive
training
25 not reported not reported not reported not reported not assessed not reported
Control 25 not reported not reported not reported not reported not assessed not reported
de Vreese
1998
Cognitive
training
9 not reported not reported not reported all 17.33 (3.39) 0
Control 9 not reported not reported not reported all 17 (3.2) 0
Quayhagen
2000
Cognitive
training
21 not reported not reported not reported not reported not assessed not reported
Control 15 not reported not reported not reported not reported not assessed not reported
Davis 2001 Cognitive
training
19 68.67 (3.86) 10:9 15.06 (3.86) 5 21.84(4.03) 0
Control 18 72.56 (7.62) 6:12 12.97 (2.56) 4 22.78 (4.45) 0
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
Koltai 2001 Cognitive
training
16 72.9 (6.7) not reported 15.0 (4.0) not reported 22.9 (3.6) 2
Control 8 73.9 (7.2) not reported 15.0 (4.0) not reported 26.6 (2.5) 0
Cahn-
Weiner
2003
Cognitive
training
19 77. 8 (6.9) 9:8 12.7 (2.1) all 24.3 (2.2) 2
Control 20 76.0 (7.7) 5:12 13.1 (3.5) all 25.1 (1.7) 3
Loewenstein
2004
Cognitive
training
28 78.12 (4.3) 15:10 13.08 (4.1) all 23.4 (2.9) 3
Control 21 74.74 (7.5) 11:8 14.37 (3.0) all 24.53 (4.5) 2
Galante
2007
Cognitive
training
7 not reported not reported not reported all 22.9 (3.1) 0
Control 4 not reported not reported not reported all 23.1 (1.8) 1
Neely 2009 Cognitive
training
10 74.8 (6.7) 6:4 not reported not reported 22.9 (4.15) 0
Control 10 77.0 (6.6) 6:4 not reported not reported 18.6 (5.7) 1
Clare 2010 Cogni-
tive rehabili-
tation
22 76.3 (6.39),
64-89
9:13 11.41 (2.81)
, 9-19
all 23.14 (3.12)
, 18-27
2
Control 22 78.1 (6.61),
56-87
9:13 11.43 (2.99)
, 9-19
all 22.32 (3.05)
, 18-30
1
Date in the table are generally reported only for those participants who completed the interventions.
Table 2. Summary of duration of interventions and timing of assessments
Study Intervention
length
Initial assess-
ment
Interim
assessment
Post-interv
assessment
Follow-up as-
sessments
Details of ses-
sions
Format of ses-
sions
Beck 1988 6 weeks week 0 n/a week 6 n/a 18 × 30- to 40-
minute
sessions
Individual
Heiss 1993 24 weeks week 0 weeks 8 and
16
(plus monthly
week 25 n/a 48 × 1-hour
sessions
Individual
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
physician ap-
pointments)
Quayhagen
1995
12 weeks week 0 n/a week 13 week 38 72 × 1-hour
caregiver-
facilitated ses-
sions
Individual
de Vreese
1998
12 weeks (af-
ter 12 weeks
on drug)
weeks 0 and
13
n/a week 26 n/a 24 × 45-
minute
sessions
Individual
Quayhagen
2000
8 weeks week 0 n/a week 12 n/a 40 × 1-hour
caregiver-
facilitated ses-
sions
Individual
Koltai 2001 5 to 6 weeks weeks 0 to 2 n/a weeks 6 to 8 n/a 5 × 1-hour ses-
sions (group)
or mean of 6
× 1-hour ses-
sions (group)
Group or indi-
vidual
Davis 2001 5 weeks week 0 n/a week 6 week 12
(cross-over)
5 × 1-hour ses-
sions
Individual
Cahn-Weiner
2003
6 weeks week 0 n/a weeks 8 to 9
(mean 59 days
post-baseline)
week
16 (mean 114.
5 days post-
baseline)
6 × 45-minute
sessions
Group
Loewenstein
2004
12 to 16 weeks week 0 n/a weeks 13 to 18 weeks 25 to 31 24 × 45-
minute
sessions
Individual
Galante 2007 4 weeks week 0 n/a week 5 3,
6 & 9 months
(MMSE only)
post-
interventions
12 × 60-
minute ses-
sions 3 times
per week
Individual
Neely 2009 8 weeks week 0 n/a week 9 n/a 8 × 60-minute
sessions
Dyads or Indi-
vidual
Clare 2010 8 weeks week 0 n/a week 9 6 months 8 × 60-minute
sessions
Individual
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A P P E N D I C E S
Appendix 1. Pre-publication search: November 2012
Source Search strategy Hits retrieved
1. ALOIS (www.medicine.ox.ac.uk/alois) Keyword search: “cognitive rehabilitation”
OR “cognitive stimulation” OR “cognitive
training”
113
2. MEDLINE In-process and other non-
indexed citations and MEDLINE 1950-
present (Ovid SP)
1. exp Dementia/
2. Delirium, Dementia, Amnestic, Cogni-
tive Disorders/
3. dement*.mp.
4. alzheimer*.mp.
5. (lewy* adj2 bod*).mp.
6. (chronic adj2 cerebrovascular).mp.
7. (“organic brain disease” or “organic brain
syndrome”).mp.
8. (cerebr* adj2 deteriorat*).mp.
9. (cerebral* adj2 insufficient*).mp.
10. (pick* adj2 disease).mp.
11. or/1-10
12. *Cognitive Therapy/
13. (cognit* adj2 stimulation).ti,ab.
14. (cognit* adj2 rehabilitation).ti,ab.
15. (cognit* adj2 training).ti,ab.
16. (cognit* adj2 retrain*).ti,ab.
17. “cognitive support”.ti,ab.
18. “memory function*”.ti,ab.
19. (memory adj2 rehabilitation).ti,ab.
20. (memory adj2 therap*).ti,ab.
21. “memory aid*”.ti,ab.
22. “memory group*”.ti,ab.
23. “memory training”.ti,ab.
24. (“memory retraining” or “memory re-
training”).ti,ab.
25. “memory support”.ti,ab.
26. “memory stimulation”.ti,ab.
27. “memory strateg*”.ti,ab.
28. “memory management”.ti,ab.
29. or/12-28
30. 11 and 29
31. randomized controlled trial.pt.
32. controlled clinical trial.pt.
33. randomized.ab.
34. placebo.ab.
35. randomly.ab.
53
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(Continued)
36. trial.ab.
37. groups.ab.
38. or/31-37
39. (animals not (humans and animals)).
sh.
40. 38 not 39
41. 30 and 40
42. (201111* or 201112*).ed.
43. 2012*.ed.
44. 42 or 43
45. 41 and 44
3. EMBASE
1980-2011 week 39 (Ovid SP)
1. exp dementia/
2. dement*.mp.
3. alzheimer*.mp.
4. (lewy* adj2 bod*).mp.
5. (chronic adj2 cerebrovascular).mp.
6. (“organic brain disease” or “organic brain
syndrome”).mp.
7. (cerebr* adj2 deteriorat*).mp.
8. (cerebral* adj2 insufficient*).mp.
9. CADASIL.mp.
10. or/1-9
11. (cognit* adj2 stimulation).ti,ab.
12. (cognit* adj2 rehabilitation).ti,ab.
13. (cognit* adj2 training).ti,ab.
14. (cognit* adj2 retrain*).ti,ab.
15. “cognitive support”.ti,ab.
16. (memory adj2 rehabilitation).ti,ab.
17. (memory adj2 therap*).ti,ab.
18. “memory aid*”.ti,ab.
19. “memory group*”.ti,ab.
20. “memory training”.ti,ab.
21. (“memory retraining” or “memory re-
training”).ti,ab.
22. “memory support”.ti,ab.
23. “memory stimulation”.ti,ab.
24. “memory strateg*”.ti,ab.
25. “memory management”.ti,ab.
26. or/11-25
27. 10 and 26
28. randomly.ab.
29. placebo*.ti,ab.
30. “double-blind*”.ti,ab.
31. randomized controlled trial/
32. trial.ti,ab.
33. or/28-32
34. 27 and 33
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35. (2011* or 2012*).em.
36. 34 and 35
4. PSYCINFO
1806-October week 5 2011 (Ovid SP)
1. exp Dementia/
2. dement*.mp.
3. alzheimer*.mp.
4. (chronic adj2 cerebrovascular).mp.
5. (“organic brain disease” or “organic brain
syndrome”).mp.
6. (cerebr* adj2 deteriorat*).mp.
7. (cerebral* adj2 insufficient*).mp.
8. or/1-7
9. (cognit* adj2 stimulation).ti,ab.
10. (cognit* adj2 rehabilitation).ti,ab.
11. (cognit* adj2 training).ti,ab.
12. (cognit* adj2 retrain*).ti,ab.
13. “cognitive support”.ti,ab.
14. (memory adj2 rehabilitation).ti,ab.
15. (memory adj2 therap*).ti,ab.
16. “memory aid*”.ti,ab.
17. “memory group*”.ti,ab.
18. “memory training”.ti,ab.
19. (“memory retraining” or “memory re-
training”).ti,ab.
20. “memory support”.ti,ab.
21. “memory stimulation”.ti,ab.
22. “memory strateg*”.ti,ab.
23. “memory management”.ti,ab.
24. or/9-23
25. 8 and 24
26. randomly.ab.
27. randomi?ed.ab.
28. placebo*.ti,ab.
29. trial.ti,ab.
30. RCT.ti,ab.
31. groups.ab.
32. or/26-31
33. 25 and 32
34. (2011* or 2012*).up.
35. 33 and 34
41
5. CINAHL (EBSCOhost) S1 (MH “Dementia+”)
S2 (MH “Delirium”) or (MH “Delir-
ium, Dementia, Amnestic, Cognitive Dis-
orders”)
S3 (MH “Wernicke’s Encephalopathy”)
S4 TX dement*
S5 TX alzheimer*
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S6 TX lewy* N2 bod*
S7 TX deliri*
S8 TX chronic N2 cerebrovascular
S9 TX “organic brain disease” or “organic
brain syndrome”
S10 TX “normal pressure hydrocephalus”
and “shunt*”
S11 TX “benign senescent forgetfulness”
S12 TX cerebr* N2 deteriorat*
S13 TX cerebral* N2 insufficient*
S14 TX pick* N2 disease
S15 TX creutzfeldt or jcd or cjd
S16 TX huntington*
S17 TX binswanger*
S18 TX korsako*
S19 S1 or S2 or S3 or S4 or S5 or S6 or S7
or S8 or S9 or S10 or S11 or S12 or S13 or
S14 or S15 or S16 or S17 or S18
S20 (MH “Rehabilitation, Cognitive”)
S21 TX (cognit* rehab*)
S22 TX (cognit* train*)
S23 TX (memory train*)
S24 TX (memory support*)
S25 TX (memory stimul*)
S26 S20 or S21 or S22 or S23 or S24 or
S25
S27 S19 and S26
S28 EM 2011
S29 EM 2012
S30 S28 or S29
S31 S27 and S30
6. Web of Science (1945-present) and con-
ference proceedings via Web of Knowledge
Topic=(dement* OR VCI OR “vascu-
lar cognitive impairment*” OR VaD OR
alzheimer*) AND Topic=(“cognit* train*”
OR “cognit* rehab*” OR “memory aid*”
OR “memory train*” OR “memory sup-
port*” OR “memory stimul*”) AND
Topic=(randomly OR placebo OR groups
OR trial OR RCT OR randomized OR
randomised) AND Year Published=(2011-
2012)
Timespan=All Years. Databases=
SCI-EXPANDED, SSCI, A&HCI, CPCI-
S, CPCI-SSH
Lemmatization=On
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7. LILACS (BIREME) demenc$ OR dement$ OR alzheimer$
[Words] and memory [Words] and ran-
domly OR randomised OR randomized
OR trial OR ensaio clínico [Words]
10
8. CENTRAL (The Cochrane Library) (Is-
sue 2 of 4, 2011)
#1 MeSH descriptor Dementia explode all
trees
#2 dement*
#3 alzheimer*
#4 “chronic cerebrovascular”
#5 “organic brain disease” or “organic brain
syndrome”
#6 “benign senescent forgetfulness”
#7 “cerebr* deteriorat*”
#8 “cerebral* insufficient*”
#9 “pick* disease”
#10 (#1 OR #2 OR #3 OR #4 OR #5 OR
#6 OR #7 OR #8 OR #9)
#11 “cognit* rehab*”
#12 “cognit* train*”
#13 “cognit* stimul*”
#14 “memory train*”
#15 “memory support*” OR “memory
aid*”
#16 “memory therap*”
#17 “memory group*”
#18 “memory stimul*” OR “memory
strateg*”
#19 (#11 OR #12 OR #13 OR #14 OR #
15 OR #16 OR #17 OR #18)
#20 (#10 AND #19)
#21 #20 AND (2011 OR 2012)
9
9. Clinicaltrials.gov (
www.clinicaltrials.gov)
Interventional Studies | dementia OR
alzheimerOR alzheimersORVCIOR vas-
cular dementia OR VaD OR vascular cog-
nitive impairment OR cadasil OR multi-
infarct OR binswanger | cognitive rehabil-
itaion OR cognitive training OR memory
| Senior
183
10. ICTRP Search Portal (http:/
/apps.who.int/trialsearch) [includes Aus-
tralian New Zealand Clinical Trials Reg-
istry; ClinicalTrilas.gov; ISRCTN;Chinese
Clinical Trial Registry; Clinical Trials Reg-
istry India; Clinical Research Information
Service Republic of Korea; German Clini-
Interventional Studies | dementia OR
Alzheimer OR vascular impairment OR
VCI OR Alzheimers | cognitive rehabili-
taion OR cognitive training ORmemory |
received from 01/11/2011 to 02/11/2012
19
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cal Trials Register; Iranian Registry of Clin-
ical Trials; Japan Primary Registries Net-
work; Pan African Clinical Trial Registry;
Sri Lanka Clinical Trials Registry; The
Netherlands National Trial Register]
TOTAL before de-duplication 633
TOTAL after de-dupe and first-assess 123
Appendix 2. Update search: December 2011
Source Search strategy Hits retrieved
1. ALOIS (www.medicine.ox.ac.uk/alois) (“cognitive training” OR “cognitive reha-
bilitation” OR “memory training”) AND
(dementia OR alzheimer) AND (2009 OR
2010 OR 2011)
129
2. MEDLINE In-process and other non-
indexed citations and MEDLINE 1950-
present (Ovid SP)
1. exp Dementia/
2. Delirium, Dementia, Amnestic, Cogni-
tive Disorders/
3. dement*.mp.
4. alzheimer*.mp.
5. (lewy* adj2 bod*).mp.
6. (chronic adj2 cerebrovascular).mp.
7. (“organic brain disease” or “organic brain
syndrome”).mp.
8. (cerebr* adj2 deteriorat*).mp.
9. (cerebral* adj2 insufficient*).mp.
10. (pick* adj2 disease).mp.
11. or/1-10
12. *Cognitive Therapy/
13. (cognit* adj2 stimulation).ti,ab.
14. (cognit* adj2 rehabilitation).ti,ab.
15. (cognit* adj2 training).ti,ab.
16. (cognit* adj2 retrain*).ti,ab.
17. “cognitive support”.ti,ab.
18. “memory function*”.ti,ab.
19. (memory adj2 rehabilitation).ti,ab.
20. (memory adj2 therap*).ti,ab.
21. “memory aid*”.ti,ab.
22. “memory group*”.ti,ab.
23. “memory training”.ti,ab.
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24. (“memory retraining” or “memory re-
training”).ti,ab.
25. “memory support”.ti,ab.
26. “memory stimulation”.ti,ab.
27. “memory strateg*”.ti,ab.
28. “memory management”.ti,ab.
29. or/12-28
30. 11 and 29
31. randomized controlled trial.pt.
32. controlled clinical trial.pt.
33. randomized.ab.
34. placebo.ab.
35. randomly.ab.
36. trial.ab.
37. groups.ab.
38. or/31-37
39. (animals not (humans and animals)).
sh.
40. 38 not 39
41. 30 and 40
42. (2009* or 2010* or 2011*).ed.
43. 41 and 42
3. EMBASE
1980-2011 week 49 (Ovid SP)
1. exp dementia/
2. dement*.mp.
3. alzheimer*.mp.
4. (lewy* adj2 bod*).mp.
5. (chronic adj2 cerebrovascular).mp.
6. (“organic brain disease” or “organic brain
syndrome”).mp.
7. (cerebr* adj2 deteriorat*).mp.
8. (cerebral* adj2 insufficient*).mp.
9. CADASIL.mp.
10. or/1-9
11. (cognit* adj2 stimulation).ti,ab.
12. (cognit* adj2 rehabilitation).ti,ab.
13. (cognit* adj2 training).ti,ab.
14. (cognit* adj2 retrain*).ti,ab.
15. “cognitive support”.ti,ab.
16. (memory adj2 rehabilitation).ti,ab.
17. (memory adj2 therap*).ti,ab.
18. “memory aid*”.ti,ab.
19. “memory group*”.ti,ab.
20. “memory training”.ti,ab.
21. (“memory retraining” or “memory re-
training”).ti,ab.
22. “memory support”.ti,ab.
23. “memory stimulation”.ti,ab.
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24. “memory strateg*”.ti,ab.
25. “memory management”.ti,ab.
26. or/11-25
27. 10 and 26
28. randomly.ab.
29. placebo*.ti,ab.
30. “double-blind*”.ti,ab.
31. randomized controlled trial/
32. trial.ti,ab.
33. or/28-32
34. 27 and 33
35. (2009* or 2010* or 2011*).em.
36. 34 and 35
4. PsycINFO
1806-December week 2 2011 (Ovid SP)
1. exp Dementia/
2. dement*.mp.
3. alzheimer*.mp.
4. (chronic adj2 cerebrovascular).mp.
5. (“organic brain disease” or “organic brain
syndrome”).mp.
6. (cerebr* adj2 deteriorat*).mp.
7. (cerebral* adj2 insufficient*).mp.
8. or/1-7
9. (cognit* adj2 stimulation).ti,ab.
10. (cognit* adj2 rehabilitation).ti,ab.
11. (cognit* adj2 training).ti,ab.
12. (cognit* adj2 retrain*).ti,ab.
13. “cognitive support”.ti,ab.
14. (memory adj2 rehabilitation).ti,ab.
15. (memory adj2 therap*).ti,ab.
16. “memory aid*”.ti,ab.
17. “memory group*”.ti,ab.
18. “memory training”.ti,ab.
19. (“memory retraining” or “memory re-
training”).ti,ab.
20. “memory support”.ti,ab.
21. “memory stimulation”.ti,ab.
22. “memory strateg*”.ti,ab.
23. “memory management”.ti,ab.
24. or/9-23
25. 8 and 24
26. randomly.ab.
27. randomi?ed.ab.
28. placebo*.ti,ab.
29. trial.ti,ab.
30. RCT.ti,ab.
31. groups.ab.
32. or/26-31
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33. 25 and 32
34. (2009* or 2010* or 2011*).up.
35. 33 and 34
5. CINAHL (EBSCOhost)
6. ISI Web of Knowledge all databases
[includes Web of Science (1945-present)
; BIOSIS Previews (1926-present); MED-
LINE (1950-present); Journal CitationRe-
ports]
Topic=(dement* OR VCI OR “vascu-
lar cognitive impairment*” OR VaD OR
alzheimer*) AND Topic=(“cognit* train*”
OR “cognit* rehab*” OR “memory aid*”
OR “memory train*” OR “memory sup-
port*” OR “memory stimul*”) AND
Topic=(randomly OR placebo OR groups
OR trial OR RCT OR randomized OR
randomised) AND Year Published=(2009-
2011)
Timespan=2009-2011.
88
7. LILACS (BIREME) memory [Words] and demenc$ OR de-
ment$ OR alzheimer$ [Words] and ran-
domly OR randomised OR randomized
OR trial OR ensaio clínico [Words]
8. CENTRAL (The Cochrane Library) (Is-
sue 4 of 4, Oct 2010)
#1 MeSH descriptor Dementia
explode all trees
#2 dement*
#3 alzheimer*
#4 “chronic cerebrovascular”
#5 “organic brain disease” or
“organic brain syndrome”
#6 “benign senescent forgetfulness”
#7 “cerebr* deteriorat*”
#8 “cerebral* insufficient*”
#9 “pick* disease”
#10 (#1 OR #2 OR #3 OR #4 OR
#5 OR #6 OR #7 OR #8 OR #9)
#11 “cognit* rehab*”
#12 “cognit* train*”
#13 “cognit* stimul*”
#14 “memory train*”
#15 “memory support*” OR
“memory aid*”
#16 “memory therap*”
#17 “memory group*”
#18 “memory stimul*”OR “memory
strateg*”
#19 (#11 OR #12 OR #13 OR #
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14 OR #15 OR #16 OR #17 OR #18)
#20 (#10 AND #19)
9. Clinicaltrials.gov (
www.clinicaltrials.gov)
Interventional Studies | dementia | cogni-
tive rehabilitaion OR cognitive training |
Senior | received from 01/01/2009 to 12/
14/2011
23
10. ICTRP Search Portal (http:/
/apps.who.int/trialsearch) [includes Aus-
tralian New Zealand Clinical Trials Reg-
istry; ClinicalTrilas.gov; ISRCTN;Chinese
Clinical Trial Registry; Clinical Trials Reg-
istry India; Clinical Research Information
Service Republic of Korea; German Clini-
cal Trials Register; Iranian Registry of Clin-
ical Trials; Japan Primary Registries Net-
work; Pan African Clinical Trial Registry;
Sri Lanka Clinical Trials Registry; The
Netherlands National Trial Register]
Interventional Studies | dementia | cogni-
tive rehabilitaion OR cognitive training |
Senior | received from 01/01/2009 to 14/
12/2011
18
TOTAL before de-duplication 489
TOTAL after de-dupe 259
Appendix 3. Update search: January 2006 to January 2009
Source Date Searched Hits Retrieved
MEDLINE (PubMed) January 7 27
EMBASE (Ovid SP) January 8 32
PsycINFO (Ovid SP) January 8 8
CINAHL (Ovid SP) January 8 7
LILACS (bireme) January 8 0
CDCIG SR* January 7 42
CENTRAL (The Cochrane Library) Issue 4 2008 48
ISTP Conference Proceedings http://
portal.isiknowledge.com/portal.cgi
January 8 32
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Australian Digital Theses Programme
http://adt.caul.edu.au/
January 12 0
Canadian Theses and Dissertations
http://www.collectionscanada.ca/
thesescanada/index-e.html
January 12 0
WHO trials register January 12 8
Current Controlled trials: Meta Register of
Controlled Trials (mRCT)
http://www.controlled-trials.com/
January 11 9
ISRCTN Register January 11 //
Nederlands Trial Register http://
www.trialregister.nl/trialreg/index.asp
January 12 0
ClinicalTrials.gov
http://www.ClinicalTrials.gov
Included in WHO portal //
IPFMA Clinical Trials Register
www.ifpma.org/clinicaltrials.html
January 12 0
UMIN Japan Trial Register
http://www.umin.ac.jp/ctr/
January 12 2
OPENsigle January 12 2
WH A T ’ S N E W
Last assessed as up-to-date: 19 December 2012.
Date Event Description
30 April 2013 New citation required but conclusions have not
changed
New lead author; conclusions unchanged
2 November 2012 New search has been performed A pre-publication search was performed for this review
on 2 November 2012
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H I S T O R Y
Protocol first published: Issue 4, 2001
Review first published: Issue 4, 2003
Date Event Description
11 December 2011 New citation required but conclusions have not
changed
A search was conducted on December 11 2011 iden-
tifying several new references for assessment
28 January 2009 New search has been performed Update searches run on 7 January 2009; a number of
results were sent to the authors for assessment
5 June 2008 Amended Converted to new review format.
14 February 2007 New search has been performed February 2007: 3 new studies were added (Cahn
Weiner 2003, Loewenstein 2004, Beck 1988); analyses
were completely re-done; minor changes were made
to background, method and discussion sections. The
conclusions of the reviewhave remained the same.This
is a minor update
22 August 2003 New citation required and conclusions have changed Substantive amendment
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Medical Subject Headings (MeSH)
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